News

JANONE CONFIRMS NAME CHANGE TO ALT5 SIGMA CORPORATION AND NEW TICKER SYMBOL TO ALTS

LAS VEGAS , July 12, 2024 /PRNewswire/ -- JanOne Inc. (Nasdaq: JAN), a multidisciplinary organization with a focus on fintech and healthcare, confirmed today that, as of market open on Monday, July 15, 2024, the Company's new name will be "ALT5 Sigma Corporation" and its Nasdaq common stock ticker symbol will change to "ALTS". This will replace the Company's current ticker symbol "JAN".

07/12/2024

JanOne Announces Plan to Enhance Stockholder Value Through Strategic Realignment

-The board has approved a strategic review of the biotech assets and ALT5 Sigma being the core focus going forward- -The company is intending a name and stock symbol change to reflect this decision- LAS VEGAS , July 10, 2024 /PRNewswire/ -- JanOne Inc. (Nasdaq: JAN), a multidisciplinary organization with a focus on fintech and healthcare, has announced plans to enhance stockholder value through a visionary strategic realignment, entailing a redeployment of biotech assets and a change of its name. The plan, unanimously approved by the company's board and following the May acquisition of fintech innovator, ALT5 Sigma, is intended to complete a strategic review with the goal of monetizing the company's biotech assets.

07/10/2024

Profitability

Dividends

Income Statement

Balance Sheet

Cash Flow Statement

Symbol Frequently Asked Questions

Is JanOne Inc. (JAN) a buy, sell, or hold?

JanOne Inc. (JAN) can hold. Click on Rating Page for detail.

What is JanOne Inc.'s stock price?

The price of JanOne Inc. (JAN) is 2.23 and it was updated on 2024-12-26 07:02:02.

Is JanOne Inc. (JAN) overvalued or undervalued?

Currently JanOne Inc. (JAN) is in undervalued.

News

From:

To:

News
3 Fintech Stocks to Sell in July Before They Crash & Burn Investors should always be aware of their current positioning in the market cycle, especially when considering fintech stocks to sell. AI greatly propelled market expansion, so much so that just 10 top stocks in the S&P 500 make up 34% of the index, breaking the previous market concentration record all the way back in the 1920s. Mon, Jul. 08, 2024
JanOne Appoints Vay Tham as its Chief Revenue Officer and President of its Fintech Subsidiary, ALT5 Sigma LAS VEGAS , June 26, 2024 /PRNewswire/ -- JanOne Inc. (Nasdaq: JAN), a multidisciplinary organization with a focus on healthcare and fintech, is pleased to announce that it has appointed Mr. Vay Tham as its Chief Revenue Officer and President of ALT5 Sigma, Inc., its wholly-owned subsidiary. Wed, Jun. 26, 2024
ALT5 SIGMA, A JANONE COMPANY, ADDS PREPAID VISA®️ CARD INTEGRATION TO ALT5 SETTLEMENT PLATFORM LAS VEGAS, June 25, 2024 /PRNewswire/ -- JanOne Inc. (Nasdaq: JAN), a multidisciplinary organization with a focus on healthcare and fintech, announced today that its wholly-owned subsidiary, ALT5 Sigma, has launched its prepaid VISA®️ Card as an extension to the previously announced ALT5 Settlement Platform. ALT5 continues to expand its digital fintech offering in the crypto world to provide functionality from traditional legacy financial models in a modernized world. Tue, Jun. 25, 2024
JanOne's Subsidiary, Alt5, Reports 91% year over year increase in Transaction Volume to US $289 million for April and May 2024 LAS VEGAS , June 13, 2024 /PRNewswire/ -- JanOne Inc. (Nasdaq: JAN), a multidisciplinary organization with a focus on healthcare and fintech, released today its wholly-owned subsidiary, ALT5 Sigma, transaction volume for April and May 2024. According to the Company, ALT5 Sigma transaction volume reached US$289 million for the months of April and May 2024 combined, compared to US$151 million in transaction volume for the months of April and May 2023 combined, representing a year-over-year increase of 91%. Thu, Jun. 13, 2024
ALT5 Sigma, a wholly-owned subsidiary of JanOne, Launches ALT5 Settlement Platform aimed at the untapped $27.3 Billion Global Digital Content Creation Market LAS VEGAS , June 11, 2024 /PRNewswire/ -- JanOne Inc. (Nasdaq: JAN), a multidisciplinary organization with a focus on healthcare and fintech, announced today that its wholly-owned subsidiary, ALT5 Sigma, has launched a new service named "ALT5 Settlement Platform" aimed at the untapped Global Digital Content Creation Market. According to JanOne, ALT5 Settlement Platform enables Digital Platforms with the ability instantaneously to pay all content creators in a cryptocurrency of their choice through ALT5 Settlement Platform APIs, including, but not limited to, Bitcoin, Ether, USDT, and USDC. Tue, Jun. 11, 2024

SEC Filings

SEC Filings
JanOne Inc. (JAN) - 8-K - Current report SEC Filings 12/19/2024
JanOne Inc. (JAN) - 4 SEC Filings 12/10/2024
JanOne Inc. (JAN) - 8-K - Current report SEC Filings 11/26/2024
JanOne Inc. (JAN) - 8-K - Current report SEC Filings 11/13/2024
JanOne Inc. (JAN) - 10-Q - Quarterly Report SEC Filings 11/12/2024
JanOne Inc. (JAN) - DEF 14A SEC Filings 11/05/2024
JanOne Inc. (JAN) - PRE 14A SEC Filings 10/29/2024
JanOne Inc. (JAN) - 4 SEC Filings 09/11/2024
JanOne Inc. (JAN) - 8-K - Current report SEC Filings 08/30/2024
JanOne Inc. (JAN) - 3 SEC Filings 08/28/2024
JanOne Inc. (JAN) - 8-K - Current report SEC Filings 08/23/2024
JanOne Inc. (JAN) - 424B5 SEC Filings 08/23/2024
JanOne Inc. (JAN) - 10-Q - Quarterly Report SEC Filings 08/19/2024
JanOne Inc. (JAN) - NT 10-Q - Quarterly Report SEC Filings 08/13/2024
JanOne Inc. (JAN) - 8-K - Current report SEC Filings 07/17/2024
JanOne Inc. (JAN) - 8-K - Current report SEC Filings 06/21/2024
JanOne Inc. (JAN) - 424B5 SEC Filings 06/21/2024
JanOne Inc. (JAN) - 8-K/A - Current report SEC Filings 06/05/2024
JanOne Inc. (JAN) - 8-K - Current report SEC Filings 06/04/2024
JanOne Inc. (JAN) - 8-K - Current report SEC Filings 05/31/2024
JanOne Inc. (JAN) - 424B5 SEC Filings 05/23/2024
JanOne Inc. (JAN) - 8-K - Current report SEC Filings 05/21/2024
JanOne Inc. (JAN) - 8-K - Current report SEC Filings 05/06/2024
JanOne Inc. (JAN) - 424B5 SEC Filings 05/06/2024
JanOne Inc. (JAN) - 10-Q - Quarterly Report SEC Filings 05/03/2024
JanOne Inc. (JAN) - S-8 SEC Filings 04/30/2024
JanOne Inc. (JAN) - EFFECT SEC Filings 04/26/2024
JanOne Inc. (JAN) - 8-K - Current report SEC Filings 04/22/2024
JanOne Inc. (JAN) - S-3 SEC Filings 04/18/2024
JanOne Inc. (JAN) - 10-K - Current report SEC Filings 04/08/2024
JanOne Inc. (JAN) - NT 10-K - Current report SEC Filings 03/29/2024
JanOne Inc. (JAN) - 8-K - Current report SEC Filings 03/15/2024
JanOne Inc. (JAN) - 8-K - Current report SEC Filings 02/28/2024
JanOne Inc. (JAN) - 8-K/A - Current report SEC Filings 02/09/2024
JanOne Inc. (JAN) - 8-K - Current report SEC Filings 02/08/2024
JanOne Inc. (JAN) - 8-K - Current report SEC Filings 01/12/2024
JanOne Inc. (JAN) - 8-K - Current report SEC Filings 10/11/2023
JanOne Inc. (JAN) - 8-K/A - Current report SEC Filings 09/22/2023
JanOne Inc. (JAN) - 8-K - Current report SEC Filings 09/15/2023
JanOne Inc. (JAN) - DEF 14A SEC Filings 08/28/2023
JanOne Inc. (JAN) - SC 13G/A SEC Filings 08/24/2023
JanOne Inc. (JAN) - 8-K - Current report SEC Filings 08/23/2023
JanOne Inc. (JAN) - 424B5 SEC Filings 08/22/2023
JanOne Inc. (JAN) - PRE 14A SEC Filings 08/16/2023
JanOne Inc. (JAN) - 10-Q - Quarterly Report SEC Filings 08/15/2023
JanOne Inc. (JAN) - 8-K/A - Current report SEC Filings 07/07/2023
JanOne Inc. (JAN) - 8-K - Current report SEC Filings 06/30/2023
JanOne Inc. (JAN) - 10-Q - Quarterly Report SEC Filings 05/22/2023
JanOne Inc. (JAN) - NT 10-Q - Quarterly Report SEC Filings 05/11/2023
JanOne Inc. (JAN) - 10-Q/A - Quarterly Report SEC Filings 04/25/2023
JanOne Inc. (JAN) - 8-K - Current report SEC Filings 04/21/2023
JanOne Inc. (JAN) - 10-K - Current report SEC Filings 04/17/2023
JanOne Inc. (JAN) - SC 13G SEC Filings 03/27/2023
JanOne Inc. (JAN) - NT 10-K - Current report SEC Filings 03/24/2023
JanOne Inc. (JAN) - 8-K - Current report SEC Filings 03/24/2023
JanOne Inc. (JAN) - 424B5 SEC Filings 03/24/2023
JanOne Inc. (JAN) - 8-K - Current report SEC Filings 03/21/2023
JanOne Inc. (JAN) - 8-K/A - Current report SEC Filings 03/20/2023
JanOne Inc. (JAN) - 8-K - Current report SEC Filings 03/20/2023
JanOne Inc. (JAN) - 8-K - Current report SEC Filings 03/15/2023
JanOne Inc. (JAN) - 8-K - Current report SEC Filings 02/13/2023
JanOne Inc. (JAN) - 8-K - Current report SEC Filings 01/31/2023
JanOne Inc. (JAN) - 4 SEC Filings 01/09/2023
JanOne Inc. (JAN) - 8-K - Current report SEC Filings 01/04/2023
JanOne Inc. (JAN) - 8-K - Current report SEC Filings 11/25/2022
JanOne Inc. (JAN) - 10-Q - Quarterly Report SEC Filings 11/14/2022
JanOne Inc. (JAN) - 8-K - Current report SEC Filings 11/03/2022
JanOne Inc. (JAN) - DEF 14A SEC Filings 10/06/2022
JanOne Inc. (JAN) - 8-K - Current report SEC Filings 09/30/2022
JanOne Inc. (JAN) - 10-Q - Quarterly Report SEC Filings 08/15/2022
JanOne Inc. (JAN) - 8-K - Current report SEC Filings 06/28/2022
JanOne Inc. (JAN) - 8-K - Current report SEC Filings 05/31/2022
JanOne Inc. (JAN) - 10-Q - Quarterly Report SEC Filings 05/12/2022
JanOne Inc. (JAN) - 8-K - Current report SEC Filings 04/15/2022
JanOne Inc. (JAN) - 10-K - Current report SEC Filings 04/01/2022
JanOne Inc. (JAN) - SC 13G/A SEC Filings 02/11/2022
JanOne Inc. (JAN) - SC 13G/A SEC Filings 02/03/2022
JanOne Inc. (JAN) - 10-Q - Quarterly Report SEC Filings 11/15/2021
JanOne Inc. (JAN) - 8-K - Current report SEC Filings 11/05/2021
JanOne Inc. (JAN) - 8-K - Current report SEC Filings 10/06/2021
JanOne Inc. (JAN) - DEF 14A SEC Filings 10/05/2021
JanOne Inc. (JAN) - 10-Q - Quarterly Report SEC Filings 08/16/2021
JanOne Inc. (JAN) - 10-Q - Quarterly Report SEC Filings 08/13/2021
JanOne Inc. (JAN) - 8-K - Current report SEC Filings 08/06/2021
JanOne Inc. (JAN) - 8-K - Current report SEC Filings 07/22/2021
JanOne Inc. (JAN) - 8-K - Current report SEC Filings 06/23/2021
JanOne Inc. (JAN) - 8-K - Current report SEC Filings 06/22/2021
JanOne Inc. (JAN) - 8-K - Current report SEC Filings 06/15/2021
JanOne Inc. (JAN) - 8-K - Current report SEC Filings 06/08/2021
JanOne Inc. (JAN) - 4 SEC Filings 05/26/2021
JanOne Inc. (JAN) - 10-Q - Quarterly Report SEC Filings 05/17/2021
JanOne Inc. (JAN) - 8-K - Current report SEC Filings 04/16/2021
JanOne Inc. (JAN) - S-8 SEC Filings 03/30/2021
JanOne Inc. (JAN) - 10-K - Current report SEC Filings 03/30/2021
JanOne Inc. (JAN) - SC 13G/A SEC Filings 03/10/2021
JanOne Inc. (JAN) - 8-K - Current report SEC Filings 02/25/2021
JanOne Inc. (JAN) - SC 13D SEC Filings 02/19/2021
JanOne Inc. (JAN) - 4 SEC Filings 02/11/2021
JanOne Inc. (JAN) - SC 13G SEC Filings 02/09/2021
JanOne Inc. (JAN) - SC 13G SEC Filings 02/08/2021
JanOne Inc. (JAN) - 8-K - Current report SEC Filings 02/02/2021
JanOne Inc. (JAN) - 424B5 SEC Filings 02/02/2021
JanOne Inc. (JAN) - SC 13G SEC Filings 02/01/2021
JanOne Inc. (JAN) - 8-K - Current report SEC Filings 01/29/2021
JanOne Inc. (JAN) - EFFECT SEC Filings 12/30/2020
JanOne Inc. (JAN) - EFFECT SEC Filings 12/29/2020
JanOne Inc. (JAN) - CORRESP SEC Filings 12/29/2020
JanOne Inc. (JAN) - UPLOAD SEC Filings 12/28/2020
JanOne Inc. (JAN) - S-3 SEC Filings 12/23/2020
JanOne Inc. (JAN) - RW SEC Filings 11/19/2020
JanOne Inc. (JAN) - 10-Q - Quarterly Report SEC Filings 11/10/2020
JanOne Inc. (JAN) - 10-Q - Quarterly Report SEC Filings 11/09/2020
JanOne Inc. (JAN) - DEF 14A SEC Filings 10/02/2020
JanOne Inc. (JAN) - 8-K - Current report SEC Filings 10/02/2020
JanOne Inc. (JAN) - 8-K - Current report SEC Filings 09/24/2020
JanOne Inc. (JAN) - 8-K - Current report SEC Filings 09/21/2020
JanOne Inc. (JAN) - S-3 SEC Filings 09/18/2020
JanOne Inc. (JAN) - 8-K - Current report SEC Filings 09/16/2020
JanOne Inc. (JAN) - PRE 14A SEC Filings 09/03/2020
JanOne Inc. (JAN) - 8-K - Current report SEC Filings 09/03/2020
JanOne Inc. (JAN) - 4/A SEC Filings 09/03/2020
JanOne Inc. (JAN) - 4 SEC Filings 09/03/2020
JanOne Inc. (JAN) - 8-K - Current report SEC Filings 08/26/2020
JanOne Inc. (JAN) - 8-K - Current report SEC Filings 08/19/2020
JanOne Inc. (JAN) - 8-K - Current report SEC Filings 08/18/2020
JanOne Inc. (JAN) - 8-K - Current report SEC Filings 08/12/2020
JanOne Inc. (JAN) - 10-Q - Quarterly Report SEC Filings 08/10/2020
JanOne Inc. (JAN) - 8-K - Current report SEC Filings 08/06/2020
JanOne Inc. (JAN) - 8-K - Current report SEC Filings 07/30/2020
JanOne Inc. (JAN) - 8-K - Current report SEC Filings 07/21/2020
JanOne Inc. (JAN) - 8-K - Current report SEC Filings 07/08/2020
JanOne Inc. (JAN) - 8-K - Current report SEC Filings 06/30/2020
JanOne Inc. (JAN) - 8-K - Current report SEC Filings 06/25/2020
JanOne Inc. (JAN) - 8-K - Current report SEC Filings 06/18/2020
JanOne Inc. (JAN) - SC 13G SEC Filings 05/18/2020
JanOne Inc. (JAN) - 10-Q - Quarterly Report SEC Filings 05/12/2020
JanOne Inc. (JAN) - 8-K - Current report SEC Filings 05/04/2020
JanOne Inc. (JAN) - 8-K/A - Current report SEC Filings 04/23/2020
JanOne Inc. (JAN) - 8-K - Current report SEC Filings 04/22/2020
JanOne Inc. (JAN) - 10-K - Current report SEC Filings 04/06/2020
JanOne Inc. (JAN) - NT 10-K - Current report SEC Filings 03/30/2020
JanOne Inc. (JAN) - 8-K - Current report SEC Filings 02/07/2020
JanOne Inc. (JAN) - 8-K - Current report SEC Filings 01/10/2020
JanOne Inc. (JAN) - 3 SEC Filings 01/10/2020
JanOne Inc. (JAN) - 8-K - Current report SEC Filings 12/03/2019
JanOne Inc. (JAN) - 8-K - Current report SEC Filings 11/25/2019
JanOne Inc. (JAN) - 10-Q - Quarterly Report SEC Filings 11/19/2019
JanOne Inc. (JAN) - 8-K - Current report SEC Filings 11/15/2019
JanOne Inc. (JAN) - 10-Q/A - Quarterly Report SEC Filings 11/15/2019
JanOne Inc. (JAN) - 10-K/A - Current report SEC Filings 11/15/2019
JanOne Inc. (JAN) - NT 10-Q - Quarterly Report SEC Filings 11/12/2019
JanOne Inc. (JAN) - 8-K - Current report SEC Filings 11/05/2019
JanOne Inc. (JAN) - DEFR14A SEC Filings 10/18/2019
JanOne Inc. (JAN) - 8-K - Current report SEC Filings 10/18/2019
JanOne Inc. (JAN) - DEF 14A SEC Filings 10/02/2019
JanOne Inc. (JAN) - 8-K - Current report SEC Filings 09/13/2019
JanOne Inc. (JAN) - 3 SEC Filings 09/12/2019
JanOne Inc. (JAN) - 8-K - Current report SEC Filings 08/30/2019
JanOne Inc. (JAN) - 10-Q - Quarterly Report SEC Filings 08/19/2019
JanOne Inc. (JAN) - NT 10-Q - Quarterly Report SEC Filings 08/14/2019
JanOne Inc. (JAN) - 8-K - Current report SEC Filings 07/01/2019
JanOne Inc. (JAN) - 8-K - Current report SEC Filings 06/25/2019
JanOne Inc. (JAN) - 8-K - Current report SEC Filings 06/24/2019
JanOne Inc. (JAN) - 8-K - Current report SEC Filings 05/21/2019
JanOne Inc. (JAN) - 10-Q - Quarterly Report SEC Filings 05/14/2019
JanOne Inc. (JAN) - 8-K - Current report SEC Filings 05/07/2019
JanOne Inc. (JAN) - SC 13G SEC Filings 04/30/2019
JanOne Inc. (JAN) - 4/A SEC Filings 04/30/2019
JanOne Inc. (JAN) - 4 SEC Filings 04/30/2019
JanOne Inc. (JAN) - 8-K - Current report SEC Filings 04/25/2019
JanOne Inc. (JAN) - 8-K - Current report SEC Filings 04/22/2019
JanOne Inc. (JAN) - SC 13D SEC Filings 04/12/2019
JanOne Inc. (JAN) - 10-K/A - Current report SEC Filings 04/02/2019
JanOne Inc. (JAN) - 10-K - Current report SEC Filings 03/29/2019
JanOne Inc. (JAN) - 8-K - Current report SEC Filings 03/21/2019
JanOne Inc. (JAN) - 8-K - Current report SEC Filings 01/18/2019
JanOne Inc. (JAN) - 8-K/A - Current report SEC Filings 01/16/2019
JanOne Inc. (JAN) - 8-K - Current report SEC Filings 01/16/2019
JanOne Inc. (JAN) - 8-K - Current report SEC Filings 01/15/2019
JanOne Inc. (JAN) - 8-K - Current report SEC Filings 12/31/2018
JanOne Inc. (JAN) - 10-Q/A - Quarterly Report SEC Filings 11/13/2018
JanOne Inc. (JAN) - 10-Q - Quarterly Report SEC Filings 11/13/2018
JanOne Inc. (JAN) - 8-K - Current report SEC Filings 10/23/2018
JanOne Inc. (JAN) - DEF 14A SEC Filings 09/18/2018
JanOne Inc. (JAN) - 8-K - Current report SEC Filings 09/18/2018
JanOne Inc. (JAN) - 3 SEC Filings 09/12/2018
JanOne Inc. (JAN) - SC 13D/A SEC Filings 09/11/2018
JanOne Inc. (JAN) - SC 13G/A SEC Filings 09/07/2018
JanOne Inc. (JAN) - 4 SEC Filings 08/30/2018
JanOne Inc. (JAN) - SC 13D/A SEC Filings 08/28/2018
JanOne Inc. (JAN) - 4 SEC Filings 08/27/2018
JanOne Inc. (JAN) - PRE 14A SEC Filings 08/24/2018
JanOne Inc. (JAN) - 4 SEC Filings 08/24/2018
JanOne Inc. (JAN) - 8-K - Current report SEC Filings 08/23/2018
JanOne Inc. (JAN) - 4 SEC Filings 08/14/2018
JanOne Inc. (JAN) - 3 SEC Filings 08/14/2018
JanOne Inc. (JAN) - 10-Q - Quarterly Report SEC Filings 08/14/2018
JanOne Inc. (JAN) - S-8 SEC Filings 08/10/2018
JanOne Inc. (JAN) - 8-K/A - Current report SEC Filings 07/05/2018
JanOne Inc. (JAN) - 8-K - Current report SEC Filings 07/05/2018
JanOne Inc. (JAN) - 10-Q - Quarterly Report SEC Filings 07/02/2018
JanOne Inc. (JAN) - SC 13G SEC Filings 06/13/2018
JanOne Inc. (JAN) - 10-K - Current report SEC Filings 06/12/2018
JanOne Inc. (JAN) - 8-K - Current report SEC Filings 05/25/2018
JanOne Inc. (JAN) - NT 10-Q - Quarterly Report SEC Filings 05/16/2018
JanOne Inc. (JAN) - 8-K - Current report SEC Filings 04/26/2018
JanOne Inc. (JAN) - 8-K - Current report SEC Filings 04/24/2018
JanOne Inc. (JAN) - NT 10-K - Current report SEC Filings 03/30/2018
JanOne Inc. (JAN) - 8-K - Current report SEC Filings 03/28/2018
JanOne Inc. (JAN) - 8-K - Current report SEC Filings 03/22/2018
JanOne Inc. (JAN) - 8-K - Current report SEC Filings 03/13/2018
JanOne Inc. (JAN) - 8-K - Current report SEC Filings 03/08/2018
JanOne Inc. (JAN) - 8-K - Current report SEC Filings 01/05/2018
JanOne Inc. (JAN) - 8-K - Current report SEC Filings 11/21/2017
JanOne Inc. (JAN) - 8-K - Current report SEC Filings 11/14/2017
JanOne Inc. (JAN) - 10-Q - Quarterly Report SEC Filings 11/14/2017
JanOne Inc. (JAN) - 8-K - Current report SEC Filings 10/27/2017
JanOne Inc. (JAN) - 10-Q/A - Quarterly Report SEC Filings 10/26/2017
JanOne Inc. (JAN) - DEF 14A SEC Filings 10/25/2017
JanOne Inc. (JAN) - 4 SEC Filings 10/12/2017
JanOne Inc. (JAN) - PRE 14A SEC Filings 10/10/2017
JanOne Inc. (JAN) - 8-K - Current report SEC Filings 10/05/2017
JanOne Inc. (JAN) - 3 SEC Filings 10/05/2017
JanOne Inc. (JAN) - 8-K - Current report SEC Filings 09/22/2017
JanOne Inc. (JAN) - 8-K - Current report SEC Filings 09/08/2017
JanOne Inc. (JAN) - SC 13D/A SEC Filings 08/29/2017
JanOne Inc. (JAN) - 4 SEC Filings 08/24/2017
JanOne Inc. (JAN) - 8-K - Current report SEC Filings 08/21/2017
JanOne Inc. (JAN) - 10-Q - Quarterly Report SEC Filings 08/21/2017
JanOne Inc. (JAN) - NT 10-Q - Quarterly Report SEC Filings 08/15/2017
JanOne Inc. (JAN) - 8-K - Current report SEC Filings 08/04/2017
JanOne Inc. (JAN) - 8-K - Current report SEC Filings 06/02/2017
JanOne Inc. (JAN) - 10-Q - Quarterly Report SEC Filings 05/16/2017
JanOne Inc. (JAN) - 4 SEC Filings 04/13/2017
JanOne Inc. (JAN) - 10-K/A - Current report SEC Filings 04/13/2017
JanOne Inc. (JAN) - SC 13D/A SEC Filings 03/31/2017
JanOne Inc. (JAN) - 10-K - Current report SEC Filings 03/31/2017
JanOne Inc. (JAN) - 8-K - Current report SEC Filings 01/31/2017
JanOne Inc. (JAN) - 8-K - Current report SEC Filings 01/05/2017
JanOne Inc. (JAN) - UPLOAD SEC Filings 12/14/2016
JanOne Inc. (JAN) - 8-K - Current report SEC Filings 12/01/2016
JanOne Inc. (JAN) - 8-K - Current report SEC Filings 11/21/2016
JanOne Inc. (JAN) - DEF 14A SEC Filings 11/18/2016
JanOne Inc. (JAN) - CORRESP SEC Filings 11/18/2016
JanOne Inc. (JAN) - 10-Q - Quarterly Report SEC Filings 11/15/2016
JanOne Inc. (JAN) - 8-K - Current report SEC Filings 11/03/2016
JanOne Inc. (JAN) - PRE 14A SEC Filings 11/01/2016
JanOne Inc. (JAN) - 8-K - Current report SEC Filings 10/28/2016
JanOne Inc. (JAN) - 3 SEC Filings 10/19/2016
JanOne Inc. (JAN) - 8-K - Current report SEC Filings 10/18/2016
JanOne Inc. (JAN) - 3 SEC Filings 08/23/2016
JanOne Inc. (JAN) - 8-K - Current report SEC Filings 08/22/2016
JanOne Inc. (JAN) - 10-Q - Quarterly Report SEC Filings 08/16/2016
JanOne Inc. (JAN) - 8-K - Current report SEC Filings 06/20/2016
JanOne Inc. (JAN) - 4 SEC Filings 05/27/2016
JanOne Inc. (JAN) - 8-K - Current report SEC Filings 05/26/2016
JanOne Inc. (JAN) - 10-Q - Quarterly Report SEC Filings 05/17/2016
JanOne Inc. (JAN) - 8-K - Current report SEC Filings 04/27/2016
JanOne Inc. (JAN) - 8-K - Current report SEC Filings 04/21/2016
JanOne Inc. (JAN) - 10-K/A - Current report SEC Filings 04/15/2016
JanOne Inc. (JAN) - 8-K - Current report SEC Filings 04/08/2016
JanOne Inc. (JAN) - NT 10-K - Current report SEC Filings 04/04/2016
JanOne Inc. (JAN) - 10-K - Current report SEC Filings 04/04/2016
JanOne Inc. (JAN) - 8-K - Current report SEC Filings 04/01/2016
JanOne Inc. (JAN) - 8-K - Current report SEC Filings 02/29/2016
JanOne Inc. (JAN) - 8-K - Current report SEC Filings 02/19/2016
JanOne Inc. (JAN) - 3 SEC Filings 01/29/2016
JanOne Inc. (JAN) - 8-K - Current report SEC Filings 01/21/2016
JanOne Inc. (JAN) - 8-K - Current report SEC Filings 12/18/2015
JanOne Inc. (JAN) - 8-K - Current report SEC Filings 12/04/2015
JanOne Inc. (JAN) - 8-K - Current report SEC Filings 12/02/2015
JanOne Inc. (JAN) - 8-K - Current report SEC Filings 12/01/2015
JanOne Inc. (JAN) - 8-K - Current report SEC Filings 11/19/2015
JanOne Inc. (JAN) - 10-Q - Quarterly Report SEC Filings 11/19/2015
JanOne Inc. (JAN) - NT 10-Q - Quarterly Report SEC Filings 11/17/2015
JanOne Inc. (JAN) - SC 13D/A SEC Filings 10/05/2015
JanOne Inc. (JAN) - 4 SEC Filings 10/05/2015
JanOne Inc. (JAN) - SC 13D/A SEC Filings 09/29/2015
JanOne Inc. (JAN) - 4 SEC Filings 09/28/2015
JanOne Inc. (JAN) - SC 13D SEC Filings 09/22/2015
JanOne Inc. (JAN) - 3 SEC Filings 09/21/2015
JanOne Inc. (JAN) - 4 SEC Filings 09/03/2015
JanOne Inc. (JAN) - 8-K - Current report SEC Filings 08/12/2015
JanOne Inc. (JAN) - 10-Q - Quarterly Report SEC Filings 08/12/2015
JanOne Inc. (JAN) - SC 13D/A SEC Filings 07/09/2015
JanOne Inc. (JAN) - 3/A SEC Filings 05/29/2015
JanOne Inc. (JAN) - 3 SEC Filings 05/28/2015
JanOne Inc. (JAN) - 8-K - Current report SEC Filings 05/27/2015
JanOne Inc. (JAN) - 10-Q - Quarterly Report SEC Filings 05/27/2015
JanOne Inc. (JAN) - 8-K - Current report SEC Filings 05/22/2015
JanOne Inc. (JAN) - NT 10-Q - Quarterly Report SEC Filings 05/20/2015
JanOne Inc. (JAN) - 8-K - Current report SEC Filings 05/18/2015
JanOne Inc. (JAN) - 10-K/A - Current report SEC Filings 05/18/2015
JanOne Inc. (JAN) - 10-K/A - Current report SEC Filings 04/17/2015
JanOne Inc. (JAN) - DEF 14A SEC Filings 04/14/2015
JanOne Inc. (JAN) - 8-K - Current report SEC Filings 03/30/2015
JanOne Inc. (JAN) - 10-K - Current report SEC Filings 03/30/2015
JanOne Inc. (JAN) - SC 13G SEC Filings 03/11/2015
JanOne Inc. (JAN) - SC 13D/A SEC Filings 02/18/2015
JanOne Inc. (JAN) - 4 SEC Filings 02/18/2015
JanOne Inc. (JAN) - 8-K - Current report SEC Filings 02/13/2015
JanOne Inc. (JAN) - 8-K - Current report SEC Filings 02/12/2015
JanOne Inc. (JAN) - SC 13D/A SEC Filings 02/04/2015
JanOne Inc. (JAN) - 5 SEC Filings 02/03/2015
JanOne Inc. (JAN) - 4 SEC Filings 02/03/2015
JanOne Inc. (JAN) - SC 13G/A SEC Filings 01/26/2015
JanOne Inc. (JAN) - SC 13D/A SEC Filings 01/16/2015
JanOne Inc. (JAN) - SC 13D/A SEC Filings 01/07/2015
JanOne Inc. (JAN) - 3 SEC Filings 12/29/2014
JanOne Inc. (JAN) - 8-K - Current report SEC Filings 12/24/2014
JanOne Inc. (JAN) - SC 13G/A SEC Filings 12/19/2014
JanOne Inc. (JAN) - SC 13D SEC Filings 12/18/2014
JanOne Inc. (JAN) - 8-K - Current report SEC Filings 11/12/2014
JanOne Inc. (JAN) - 10-Q - Quarterly Report SEC Filings 11/07/2014
JanOne Inc. (JAN) - 8-K - Current report SEC Filings 11/03/2014
JanOne Inc. (JAN) - 8-K - Current report SEC Filings 10/22/2014
JanOne Inc. (JAN) - 8-K - Current report SEC Filings 08/18/2014
JanOne Inc. (JAN) - 10-Q - Quarterly Report SEC Filings 08/11/2014
JanOne Inc. (JAN) - 8-K - Current report SEC Filings 08/06/2014
JanOne Inc. (JAN) - 8-K - Current report SEC Filings 07/24/2014
JanOne Inc. (JAN) - 4 SEC Filings 05/13/2014
JanOne Inc. (JAN) - 8-K - Current report SEC Filings 05/09/2014
JanOne Inc. (JAN) - 10-Q - Quarterly Report SEC Filings 05/09/2014
JanOne Inc. (JAN) - 8-K - Current report SEC Filings 05/05/2014
JanOne Inc. (JAN) - 8-K - Current report SEC Filings 04/23/2014
JanOne Inc. (JAN) - DEF 14A SEC Filings 03/27/2014
JanOne Inc. (JAN) - 10-K - Current report SEC Filings 03/14/2014
JanOne Inc. (JAN) - SC 13D/A SEC Filings 03/12/2014
JanOne Inc. (JAN) - 4 SEC Filings 02/27/2014
JanOne Inc. (JAN) - 8-K - Current report SEC Filings 02/24/2014
JanOne Inc. (JAN) - UPLOAD SEC Filings 02/20/2014
JanOne Inc. (JAN) - CORRESP SEC Filings 02/10/2014
JanOne Inc. (JAN) - 8-K - Current report SEC Filings 02/10/2014
JanOne Inc. (JAN) - SC 13G/A SEC Filings 02/07/2014
JanOne Inc. (JAN) - 4 SEC Filings 02/06/2014
JanOne Inc. (JAN) - UPLOAD SEC Filings 01/27/2014
JanOne Inc. (JAN) - CORRESP SEC Filings 01/10/2014
JanOne Inc. (JAN) - UPLOAD SEC Filings 12/27/2013
JanOne Inc. (JAN) - CT ORDER SEC Filings 11/18/2013
JanOne Inc. (JAN) - 4 SEC Filings 11/15/2013
JanOne Inc. (JAN) - 10-Q - Quarterly Report SEC Filings 11/07/2013
JanOne Inc. (JAN) - 8-K - Current report SEC Filings 11/04/2013
JanOne Inc. (JAN) - 8-K - Current report SEC Filings 10/23/2013
JanOne Inc. (JAN) - 8-K/A - Current report SEC Filings 09/30/2013
JanOne Inc. (JAN) - 4 SEC Filings 08/23/2013
JanOne Inc. (JAN) - 144/A SEC Filings 08/23/2013
JanOne Inc. (JAN) - 4 SEC Filings 08/15/2013
JanOne Inc. (JAN) - 4/A SEC Filings 08/14/2013
JanOne Inc. (JAN) - 4 SEC Filings 08/14/2013
JanOne Inc. (JAN) - 10-Q - Quarterly Report SEC Filings 08/08/2013
JanOne Inc. (JAN) - 8-K - Current report SEC Filings 08/05/2013
JanOne Inc. (JAN) - 8-K - Current report SEC Filings 07/26/2013
JanOne Inc. (JAN) - 8-K - Current report SEC Filings 07/24/2013
JanOne Inc. (JAN) - 4 SEC Filings 07/24/2013
JanOne Inc. (JAN) - 3 SEC Filings 07/24/2013
JanOne Inc. (JAN) - 8-K - Current report SEC Filings 05/14/2013
JanOne Inc. (JAN) - 4 SEC Filings 05/13/2013
JanOne Inc. (JAN) - 10-Q - Quarterly Report SEC Filings 05/09/2013
JanOne Inc. (JAN) - 8-K - Current report SEC Filings 05/06/2013
JanOne Inc. (JAN) - 8-K - Current report SEC Filings 04/24/2013
JanOne Inc. (JAN) - DEF 14A SEC Filings 03/26/2013
JanOne Inc. (JAN) - 10-K - Current report SEC Filings 03/22/2013
JanOne Inc. (JAN) - 8-K - Current report SEC Filings 02/27/2013
JanOne Inc. (JAN) - SC 13D/A SEC Filings 02/26/2013
JanOne Inc. (JAN) - 8-K - Current report SEC Filings 02/15/2013
JanOne Inc. (JAN) - SC 13G/A SEC Filings 02/01/2013
JanOne Inc. (JAN) - 4/A SEC Filings 01/08/2013
JanOne Inc. (JAN) - SC 13D/A SEC Filings 12/12/2012
JanOne Inc. (JAN) - 4 SEC Filings 11/28/2012
JanOne Inc. (JAN) - 4/A SEC Filings 11/27/2012
JanOne Inc. (JAN) - 4 SEC Filings 11/27/2012
JanOne Inc. (JAN) - 10-Q - Quarterly Report SEC Filings 11/09/2012
JanOne Inc. (JAN) - 8-K - Current report SEC Filings 11/05/2012
JanOne Inc. (JAN) - 8-K - Current report SEC Filings 10/22/2012
JanOne Inc. (JAN) - 3 SEC Filings 10/02/2012
JanOne Inc. (JAN) - 8-K - Current report SEC Filings 10/01/2012
JanOne Inc. (JAN) - 10-Q - Quarterly Report SEC Filings 08/10/2012
JanOne Inc. (JAN) - 4 SEC Filings 08/09/2012
JanOne Inc. (JAN) - 3 SEC Filings 08/09/2012
JanOne Inc. (JAN) - 8-K - Current report SEC Filings 08/06/2012
JanOne Inc. (JAN) - 8-K - Current report SEC Filings 07/23/2012
JanOne Inc. (JAN) - 4 SEC Filings 05/14/2012
JanOne Inc. (JAN) - 8-K - Current report SEC Filings 05/11/2012
JanOne Inc. (JAN) - 10-Q - Quarterly Report SEC Filings 05/10/2012
JanOne Inc. (JAN) - 8-K - Current report SEC Filings 05/07/2012
JanOne Inc. (JAN) - 8-K - Current report SEC Filings 04/25/2012
JanOne Inc. (JAN) - DEF 14A SEC Filings 03/29/2012
JanOne Inc. (JAN) - EFFECT SEC Filings 03/20/2012
JanOne Inc. (JAN) - 10-K - Current report SEC Filings 03/15/2012
JanOne Inc. (JAN) - POS AM SEC Filings 03/14/2012
JanOne Inc. (JAN) - 4 SEC Filings 03/06/2012
JanOne Inc. (JAN) - 3/A SEC Filings 03/01/2012
JanOne Inc. (JAN) - 3 SEC Filings 02/29/2012
JanOne Inc. (JAN) - 8-K - Current report SEC Filings 02/28/2012
JanOne Inc. (JAN) - 8-K - Current report SEC Filings 02/27/2012
JanOne Inc. (JAN) - 8-K - Current report SEC Filings 02/13/2012
JanOne Inc. (JAN) - SC 13G/A SEC Filings 02/03/2012
JanOne Inc. (JAN) - 10-Q - Quarterly Report SEC Filings 11/10/2011
JanOne Inc. (JAN) - 8-K - Current report SEC Filings 11/04/2011
JanOne Inc. (JAN) - 8-K - Current report SEC Filings 10/27/2011
JanOne Inc. (JAN) - S-8 SEC Filings 08/31/2011
JanOne Inc. (JAN) - 10-Q - Quarterly Report SEC Filings 08/15/2011
JanOne Inc. (JAN) - 8-K - Current report SEC Filings 08/08/2011
JanOne Inc. (JAN) - 8-K - Current report SEC Filings 08/05/2011
JanOne Inc. (JAN) - 4 SEC Filings 08/04/2011
JanOne Inc. (JAN) - 3 SEC Filings 08/04/2011
JanOne Inc. (JAN) - 8-K - Current report SEC Filings 07/21/2011
JanOne Inc. (JAN) - 8-K - Current report SEC Filings 05/16/2011
JanOne Inc. (JAN) - 4 SEC Filings 05/16/2011
JanOne Inc. (JAN) - 10-Q - Quarterly Report SEC Filings 05/13/2011
JanOne Inc. (JAN) - 8-K - Current report SEC Filings 05/09/2011
JanOne Inc. (JAN) - 8-K - Current report SEC Filings 04/19/2011
JanOne Inc. (JAN) - DEF 14A SEC Filings 03/31/2011
JanOne Inc. (JAN) - 10-K - Current report SEC Filings 03/17/2011
JanOne Inc. (JAN) - 8-K - Current report SEC Filings 03/16/2011
JanOne Inc. (JAN) - 8-K - Current report SEC Filings 02/28/2011
JanOne Inc. (JAN) - 8-K - Current report SEC Filings 02/22/2011
JanOne Inc. (JAN) - SC 13G/A SEC Filings 02/09/2011
JanOne Inc. (JAN) - UPLOAD SEC Filings 02/02/2011
JanOne Inc. (JAN) - 8-K - Current report SEC Filings 01/31/2011
JanOne Inc. (JAN) - 10-K/A - Current report SEC Filings 01/28/2011
JanOne Inc. (JAN) - CORRESP SEC Filings 01/07/2011
JanOne Inc. (JAN) - 8-K - Current report SEC Filings 01/06/2011
JanOne Inc. (JAN) - 3 SEC Filings 01/06/2011
JanOne Inc. (JAN) - UPLOAD SEC Filings 12/08/2010
JanOne Inc. (JAN) - CORRESP SEC Filings 11/22/2010
JanOne Inc. (JAN) - D SEC Filings 11/17/2010
JanOne Inc. (JAN) - 10-Q - Quarterly Report SEC Filings 11/15/2010
JanOne Inc. (JAN) - 8-K - Current report SEC Filings 11/09/2010
JanOne Inc. (JAN) - UPLOAD SEC Filings 11/02/2010
JanOne Inc. (JAN) - 8-K - Current report SEC Filings 10/27/2010
JanOne Inc. (JAN) - SC 13D SEC Filings 10/25/2010
JanOne Inc. (JAN) - 4 SEC Filings 08/17/2010
JanOne Inc. (JAN) - 10-Q - Quarterly Report SEC Filings 08/16/2010
JanOne Inc. (JAN) - 8-K - Current report SEC Filings 08/12/2010
JanOne Inc. (JAN) - 8-K - Current report SEC Filings 08/04/2010
JanOne Inc. (JAN) - EFFECT SEC Filings 07/30/2010
JanOne Inc. (JAN) - 424B3 SEC Filings 07/29/2010
JanOne Inc. (JAN) - 8-K - Current report SEC Filings 06/03/2010
JanOne Inc. (JAN) - S-3/A SEC Filings 05/19/2010
JanOne Inc. (JAN) - 8-K - Current report SEC Filings 05/19/2010
JanOne Inc. (JAN) - 10-Q - Quarterly Report SEC Filings 05/18/2010
JanOne Inc. (JAN) - 4 SEC Filings 05/17/2010
JanOne Inc. (JAN) - 8-K - Current report SEC Filings 05/11/2010
JanOne Inc. (JAN) - S-3 SEC Filings 05/06/2010
JanOne Inc. (JAN) - 8-K - Current report SEC Filings 05/05/2010
JanOne Inc. (JAN) - SC 13D SEC Filings 04/26/2010
JanOne Inc. (JAN) - D SEC Filings 04/08/2010
JanOne Inc. (JAN) - 8-K - Current report SEC Filings 04/08/2010
JanOne Inc. (JAN) - DEF 14A SEC Filings 04/01/2010
JanOne Inc. (JAN) - CT ORDER SEC Filings 03/24/2010
JanOne Inc. (JAN) - 10-K - Current report SEC Filings 03/18/2010
JanOne Inc. (JAN) - SC 13D SEC Filings 03/09/2010
JanOne Inc. (JAN) - 8-K - Current report SEC Filings 03/01/2010
JanOne Inc. (JAN) - 8-K - Current report SEC Filings 02/23/2010
JanOne Inc. (JAN) - SC 13G/A SEC Filings 02/01/2010
JanOne Inc. (JAN) - 4 SEC Filings 12/31/2009
JanOne Inc. (JAN) - S-8 SEC Filings 12/17/2009
JanOne Inc. (JAN) - 10-Q - Quarterly Report SEC Filings 11/12/2009
JanOne Inc. (JAN) - 8-K - Current report SEC Filings 11/09/2009
JanOne Inc. (JAN) - 8-K - Current report SEC Filings 10/26/2009
JanOne Inc. (JAN) - 8-K - Current report SEC Filings 10/01/2009
JanOne Inc. (JAN) - 10-Q - Quarterly Report SEC Filings 08/14/2009
JanOne Inc. (JAN) - 4 SEC Filings 08/13/2009
JanOne Inc. (JAN) - 8-K - Current report SEC Filings 08/12/2009
JanOne Inc. (JAN) - 8-K - Current report SEC Filings 08/11/2009
JanOne Inc. (JAN) - 8-K - Current report SEC Filings 08/05/2009
JanOne Inc. (JAN) - 10-Q - Quarterly Report SEC Filings 05/18/2009
JanOne Inc. (JAN) - 8-K - Current report SEC Filings 05/12/2009
JanOne Inc. (JAN) - DEF 14A SEC Filings 04/02/2009
JanOne Inc. (JAN) - 4/A SEC Filings 04/01/2009
JanOne Inc. (JAN) - 4 SEC Filings 04/01/2009
JanOne Inc. (JAN) - 3 SEC Filings 04/01/2009
JanOne Inc. (JAN) - 10-K - Current report SEC Filings 03/20/2009
JanOne Inc. (JAN) - SC 13D SEC Filings 03/11/2009
JanOne Inc. (JAN) - 8-K - Current report SEC Filings 03/05/2009
JanOne Inc. (JAN) - SC 13G/A SEC Filings 01/23/2009
JanOne Inc. (JAN) - SC 13D SEC Filings 12/04/2008
JanOne Inc. (JAN) - 10-Q - Quarterly Report SEC Filings 11/05/2008
JanOne Inc. (JAN) - 8-K - Current report SEC Filings 10/30/2008
JanOne Inc. (JAN) - 10-Q - Quarterly Report SEC Filings 08/08/2008
JanOne Inc. (JAN) - 8-K - Current report SEC Filings 08/01/2008
JanOne Inc. (JAN) - 8-K - Current report SEC Filings 07/17/2008
JanOne Inc. (JAN) - 10-Q - Quarterly Report SEC Filings 05/13/2008
JanOne Inc. (JAN) - 8-K - Current report SEC Filings 05/09/2008
JanOne Inc. (JAN) - DEF 14A SEC Filings 04/11/2008
JanOne Inc. (JAN) - 4 SEC Filings 04/02/2008
JanOne Inc. (JAN) - UPLOAD SEC Filings 03/31/2008
JanOne Inc. (JAN) - UPLOAD SEC Filings 03/28/2008
JanOne Inc. (JAN) - 10-K - Current report SEC Filings 03/28/2008
JanOne Inc. (JAN) - CORRESP SEC Filings 03/24/2008
JanOne Inc. (JAN) - 8-K - Current report SEC Filings 03/21/2008
JanOne Inc. (JAN) - SC 13G/A SEC Filings 03/07/2008
JanOne Inc. (JAN) - 8-K - Current report SEC Filings 02/29/2008
JanOne Inc. (JAN) - SC 13G/A SEC Filings 02/08/2008
JanOne Inc. (JAN) - 4 SEC Filings 01/24/2008
JanOne Inc. (JAN) - SC 13G/A SEC Filings 01/11/2008
JanOne Inc. (JAN) - 8-K - Current report SEC Filings 01/11/2008
JanOne Inc. (JAN) - CORRESP SEC Filings 01/09/2008
JanOne Inc. (JAN) - 4 SEC Filings 01/07/2008
JanOne Inc. (JAN) - 8-K - Current report SEC Filings 01/03/2008
JanOne Inc. (JAN) - SC 13G/A SEC Filings 12/07/2007
JanOne Inc. (JAN) - UPLOAD SEC Filings 11/27/2007
JanOne Inc. (JAN) - NT 10-Q - Quarterly Report SEC Filings 11/14/2007
JanOne Inc. (JAN) - 10-Q - Quarterly Report SEC Filings 11/14/2007
JanOne Inc. (JAN) - 4 SEC Filings 11/09/2007
JanOne Inc. (JAN) - 8-K - Current report SEC Filings 10/31/2007
JanOne Inc. (JAN) - SC 13G/A SEC Filings 10/09/2007
JanOne Inc. (JAN) - 8-K - Current report SEC Filings 10/09/2007
JanOne Inc. (JAN) - 4 SEC Filings 08/24/2007
JanOne Inc. (JAN) - 4 SEC Filings 08/20/2007
JanOne Inc. (JAN) - 10-Q - Quarterly Report SEC Filings 08/14/2007
JanOne Inc. (JAN) - 4 SEC Filings 08/09/2007
JanOne Inc. (JAN) - 8-K - Current report SEC Filings 08/06/2007
JanOne Inc. (JAN) - 8-K - Current report SEC Filings 06/21/2007
JanOne Inc. (JAN) - 4 SEC Filings 06/04/2007
JanOne Inc. (JAN) - 4 SEC Filings 06/01/2007
JanOne Inc. (JAN) - 4 SEC Filings 05/25/2007
JanOne Inc. (JAN) - 8-K - Current report SEC Filings 05/24/2007
JanOne Inc. (JAN) - 4 SEC Filings 05/23/2007
JanOne Inc. (JAN) - 4 SEC Filings 05/16/2007
JanOne Inc. (JAN) - 10-Q - Quarterly Report SEC Filings 05/14/2007
JanOne Inc. (JAN) - 8-K - Current report SEC Filings 05/10/2007
JanOne Inc. (JAN) - 8-K - Current report SEC Filings 05/02/2007
JanOne Inc. (JAN) - ARS SEC Filings 04/09/2007
JanOne Inc. (JAN) - SC 13D/A SEC Filings 04/06/2007
JanOne Inc. (JAN) - DEF 14A SEC Filings 04/06/2007
JanOne Inc. (JAN) - 4 SEC Filings 04/06/2007
JanOne Inc. (JAN) - 8-K - Current report SEC Filings 04/03/2007
JanOne Inc. (JAN) - 10-K - Current report SEC Filings 03/29/2007
JanOne Inc. (JAN) - 8-K - Current report SEC Filings 02/27/2007
JanOne Inc. (JAN) - SC 13G/A SEC Filings 02/09/2007
JanOne Inc. (JAN) - SC 13G/A SEC Filings 01/12/2007
JanOne Inc. (JAN) - 10-Q - Quarterly Report SEC Filings 11/14/2006
JanOne Inc. (JAN) - 8-K - Current report SEC Filings 11/09/2006
JanOne Inc. (JAN) - 8-K - Current report SEC Filings 10/27/2006
JanOne Inc. (JAN) - SC 13G/A SEC Filings 10/06/2006
JanOne Inc. (JAN) - SC 13G/A SEC Filings 09/05/2006
JanOne Inc. (JAN) - 10-Q - Quarterly Report SEC Filings 08/15/2006
JanOne Inc. (JAN) - 8-K - Current report SEC Filings 08/08/2006
JanOne Inc. (JAN) - 4 SEC Filings 07/07/2006
JanOne Inc. (JAN) - 8-K - Current report SEC Filings 07/06/2006
JanOne Inc. (JAN) - 8-K - Current report SEC Filings 07/05/2006
JanOne Inc. (JAN) - 8-K - Current report SEC Filings 07/03/2006
JanOne Inc. (JAN) - 8-K - Current report SEC Filings 06/23/2006
JanOne Inc. (JAN) - 4 SEC Filings 06/14/2006
JanOne Inc. (JAN) - 4 SEC Filings 05/19/2006
JanOne Inc. (JAN) - 10-Q - Quarterly Report SEC Filings 05/16/2006
JanOne Inc. (JAN) - 4 SEC Filings 05/12/2006
JanOne Inc. (JAN) - 8-K - Current report SEC Filings 05/08/2006
JanOne Inc. (JAN) - ARS SEC Filings 04/05/2006
JanOne Inc. (JAN) - 4 SEC Filings 04/05/2006
JanOne Inc. (JAN) - DEF 14A SEC Filings 03/31/2006
JanOne Inc. (JAN) - 10-K - Current report SEC Filings 03/31/2006
JanOne Inc. (JAN) - 8-K - Current report SEC Filings 03/22/2006
JanOne Inc. (JAN) - 8-K - Current report SEC Filings 02/21/2006
JanOne Inc. (JAN) - SC 13G SEC Filings 02/10/2006
JanOne Inc. (JAN) - SC 13G SEC Filings 02/03/2006
JanOne Inc. (JAN) - SC 13G/A SEC Filings 01/27/2006
JanOne Inc. (JAN) - 8-K - Current report SEC Filings 12/13/2005
JanOne Inc. (JAN) - 8-K - Current report SEC Filings 12/01/2005
JanOne Inc. (JAN) - 4 SEC Filings 11/23/2005
JanOne Inc. (JAN) - 4 SEC Filings 11/18/2005
JanOne Inc. (JAN) - 8-K - Current report SEC Filings 11/15/2005
JanOne Inc. (JAN) - 10-Q - Quarterly Report SEC Filings 11/15/2005
JanOne Inc. (JAN) - 8-K - Current report SEC Filings 11/09/2005
JanOne Inc. (JAN) - 8-K - Current report SEC Filings 09/23/2005
JanOne Inc. (JAN) - 4 SEC Filings 08/31/2005
JanOne Inc. (JAN) - 4 SEC Filings 08/22/2005
JanOne Inc. (JAN) - 10-Q - Quarterly Report SEC Filings 08/16/2005
JanOne Inc. (JAN) - SC 13D/A SEC Filings 08/11/2005
JanOne Inc. (JAN) - 4 SEC Filings 08/10/2005
JanOne Inc. (JAN) - 4 SEC Filings 08/08/2005
JanOne Inc. (JAN) - 8-K - Current report SEC Filings 08/02/2005
JanOne Inc. (JAN) - UPLOAD SEC Filings 07/18/2005
JanOne Inc. (JAN) - S-8 SEC Filings 06/29/2005
JanOne Inc. (JAN) - 3 SEC Filings 06/22/2005
JanOne Inc. (JAN) - 8-K - Current report SEC Filings 06/20/2005
JanOne Inc. (JAN) - CORRESP SEC Filings 06/17/2005
JanOne Inc. (JAN) - 4/A SEC Filings 05/25/2005
JanOne Inc. (JAN) - 4 SEC Filings 05/24/2005
JanOne Inc. (JAN) - 4 SEC Filings 05/19/2005
JanOne Inc. (JAN) - 4 SEC Filings 05/18/2005
JanOne Inc. (JAN) - 10-Q - Quarterly Report SEC Filings 05/17/2005
JanOne Inc. (JAN) - 8-K - Current report SEC Filings 04/27/2005
JanOne Inc. (JAN) - 8-K - Current report SEC Filings 04/25/2005
JanOne Inc. (JAN) - 424B3 SEC Filings 04/22/2005
JanOne Inc. (JAN) - S-2/A SEC Filings 04/21/2005
JanOne Inc. (JAN) - CORRESP SEC Filings 04/21/2005
JanOne Inc. (JAN) - CORRESP SEC Filings 04/20/2005
JanOne Inc. (JAN) - S-2/A SEC Filings 04/19/2005
JanOne Inc. (JAN) - CORRESP SEC Filings 04/19/2005
JanOne Inc. (JAN) - S-2/A SEC Filings 04/15/2005
JanOne Inc. (JAN) - 8-K - Current report SEC Filings 04/07/2005
JanOne Inc. (JAN) - ARS SEC Filings 04/04/2005
JanOne Inc. (JAN) - DEF 14A SEC Filings 04/01/2005
JanOne Inc. (JAN) - 8-K - Current report SEC Filings 04/01/2005
JanOne Inc. (JAN) - 10-K - Current report SEC Filings 04/01/2005
JanOne Inc. (JAN) - UPLOAD SEC Filings 03/09/2005
JanOne Inc. (JAN) - S-2 SEC Filings 02/25/2005
JanOne Inc. (JAN) - SC 13G SEC Filings 02/14/2005
JanOne Inc. (JAN) - SC 13G/A SEC Filings 02/10/2005
JanOne Inc. (JAN) - 8-K - Current report SEC Filings 02/09/2005
JanOne Inc. (JAN) - 4 SEC Filings 01/21/2005
JanOne Inc. (JAN) - REGDEX SEC Filings 01/05/2005
JanOne Inc. (JAN) - 8-K - Current report SEC Filings 01/05/2005
JanOne Inc. (JAN) - 8-K - Current report SEC Filings 12/16/2004
JanOne Inc. (JAN) - 8-K - Current report SEC Filings 12/15/2004
JanOne Inc. (JAN) - SC 13G/A SEC Filings 12/10/2004
JanOne Inc. (JAN) - 10-Q - Quarterly Report SEC Filings 11/16/2004
JanOne Inc. (JAN) - 8-K - Current report SEC Filings 11/03/2004
JanOne Inc. (JAN) - 8-K - Current report SEC Filings 10/21/2004
JanOne Inc. (JAN) - 8-K - Current report SEC Filings 10/08/2004
JanOne Inc. (JAN) - 10-Q - Quarterly Report SEC Filings 08/17/2004
JanOne Inc. (JAN) - 8-K - Current report SEC Filings 08/13/2004
JanOne Inc. (JAN) - 8-K - Current report SEC Filings 08/12/2004
JanOne Inc. (JAN) - 8-K - Current report SEC Filings 07/30/2004
JanOne Inc. (JAN) - SC 13D/A SEC Filings 06/25/2004
JanOne Inc. (JAN) - 4 SEC Filings 06/25/2004
JanOne Inc. (JAN) - 3 SEC Filings 06/25/2004
JanOne Inc. (JAN) - 4 SEC Filings 05/24/2004
JanOne Inc. (JAN) - 10-Q - Quarterly Report SEC Filings 05/18/2004
JanOne Inc. (JAN) - 4 SEC Filings 05/11/2004
JanOne Inc. (JAN) - 8-K - Current report SEC Filings 05/03/2004
JanOne Inc. (JAN) - 4 SEC Filings 04/14/2004
JanOne Inc. (JAN) - DEF 14A SEC Filings 03/26/2004
JanOne Inc. (JAN) - 10-K - Current report SEC Filings 03/26/2004
JanOne Inc. (JAN) - 8-K - Current report SEC Filings 03/18/2004
JanOne Inc. (JAN) - 8-K - Current report SEC Filings 02/06/2004
JanOne Inc. (JAN) - SC 13G/A SEC Filings 02/04/2004
JanOne Inc. (JAN) - 10-Q - Quarterly Report SEC Filings 11/12/2003
JanOne Inc. (JAN) - 8-K - Current report SEC Filings 10/30/2003
JanOne Inc. (JAN) - 8-K - Current report SEC Filings 09/12/2003
JanOne Inc. (JAN) - 8-K - Current report SEC Filings 09/10/2003
JanOne Inc. (JAN) - 8-K - Current report SEC Filings 08/21/2003
JanOne Inc. (JAN) - 10-Q - Quarterly Report SEC Filings 08/12/2003
JanOne Inc. (JAN) - 8-K - Current report SEC Filings 05/15/2003
JanOne Inc. (JAN) - 10-Q - Quarterly Report SEC Filings 05/13/2003
JanOne Inc. (JAN) - DEF 14A SEC Filings 03/21/2003
JanOne Inc. (JAN) - 10-K - Current report SEC Filings 03/21/2003
JanOne Inc. (JAN) - 8-K - Current report SEC Filings 03/18/2003
JanOne Inc. (JAN) - 8-K - Current report SEC Filings 03/11/2003
JanOne Inc. (JAN) - SC 13G/A SEC Filings 02/03/2003
JanOne Inc. (JAN) - 8-K - Current report SEC Filings 01/24/2003
JanOne Inc. (JAN) - 8-K - Current report SEC Filings 01/14/2003
JanOne Inc. (JAN) - 8-K - Current report SEC Filings 12/23/2002
JanOne Inc. (JAN) - 10-Q - Quarterly Report SEC Filings 11/12/2002
JanOne Inc. (JAN) - 8-K - Current report SEC Filings 11/06/2002
JanOne Inc. (JAN) - S-8 POS SEC Filings 09/04/2002
JanOne Inc. (JAN) - 10-Q - Quarterly Report SEC Filings 08/13/2002
JanOne Inc. (JAN) - 8-K - Current report SEC Filings 08/07/2002
JanOne Inc. (JAN) - 10-Q - Quarterly Report SEC Filings 05/14/2002
JanOne Inc. (JAN) - 8-K - Current report SEC Filings 04/25/2002
JanOne Inc. (JAN) - 8-K - Current report SEC Filings 04/10/2002
JanOne Inc. (JAN) - DEF 14A SEC Filings 03/22/2002
JanOne Inc. (JAN) - 10-K - Current report SEC Filings 03/22/2002
JanOne Inc. (JAN) - 8-K - Current report SEC Filings 03/07/2002
JanOne Inc. (JAN) - 8-K - Current report SEC Filings 02/22/2002
JanOne Inc. (JAN) - SC 13G/A SEC Filings 01/29/2002
JanOne Inc. (JAN) - S-8 POS SEC Filings 12/03/2001
JanOne Inc. (JAN) - 8-K - Current report SEC Filings 11/13/2001
JanOne Inc. (JAN) - 10-Q - Quarterly Report SEC Filings 11/13/2001
JanOne Inc. (JAN) - 8-K - Current report SEC Filings 10/30/2001
JanOne Inc. (JAN) - 8-K - Current report SEC Filings 09/27/2001
JanOne Inc. (JAN) - 8-K - Current report SEC Filings 09/05/2001
JanOne Inc. (JAN) - 10-Q - Quarterly Report SEC Filings 08/14/2001
JanOne Inc. (JAN) - 8-K - Current report SEC Filings 08/02/2001
JanOne Inc. (JAN) - 8-K - Current report SEC Filings 06/25/2001
JanOne Inc. (JAN) - 10-Q - Quarterly Report SEC Filings 05/15/2001
JanOne Inc. (JAN) - DEF 14A SEC Filings 03/23/2001
JanOne Inc. (JAN) - 10-K - Current report SEC Filings 03/23/2001
JanOne Inc. (JAN) - SC 13D/A SEC Filings 02/14/2001
JanOne Inc. (JAN) - SC 13G/A SEC Filings 01/22/2001
JanOne Inc. (JAN) - 10-Q - Quarterly Report SEC Filings 11/14/2000
JanOne Inc. (JAN) - 10-Q - Quarterly Report SEC Filings 08/15/2000
JanOne Inc. (JAN) - 10-Q - Quarterly Report SEC Filings 05/16/2000
JanOne Inc. (JAN) - SC 13G SEC Filings 04/14/2000
JanOne Inc. (JAN) - S-8 SEC Filings 03/28/2000
JanOne Inc. (JAN) - DEF 14A SEC Filings 03/24/2000
JanOne Inc. (JAN) - 10-K - Current report SEC Filings 03/24/2000
JanOne Inc. (JAN) - SC 13D SEC Filings 03/16/2000
JanOne Inc. (JAN) - SC 13D SEC Filings 02/10/2000
JanOne Inc. (JAN) - SC 13G/A SEC Filings 02/02/2000
JanOne Inc. (JAN) - S-8 POS SEC Filings 12/30/1999
JanOne Inc. (JAN) - 10-Q - Quarterly Report SEC Filings 11/16/1999
JanOne Inc. (JAN) - 10-Q - Quarterly Report SEC Filings 08/17/1999
JanOne Inc. (JAN) - 424B2 SEC Filings 07/09/1999
JanOne Inc. (JAN) - S-2 SEC Filings 06/21/1999
JanOne Inc. (JAN) - 10-Q - Quarterly Report SEC Filings 05/18/1999
JanOne Inc. (JAN) - SC 13D SEC Filings 04/09/1999
JanOne Inc. (JAN) - DEF 14A SEC Filings 03/26/1999
JanOne Inc. (JAN) - 10-K - Current report SEC Filings 03/26/1999
JanOne Inc. (JAN) - SC 13G/A SEC Filings 03/10/1999
JanOne Inc. (JAN) - SC 13D SEC Filings 02/12/1999
JanOne Inc. (JAN) - SC 13G/A SEC Filings 02/04/1999
JanOne Inc. (JAN) - 10-Q - Quarterly Report SEC Filings 11/16/1998
JanOne Inc. (JAN) - 8-K - Current report SEC Filings 09/09/1998
JanOne Inc. (JAN) - 10-Q - Quarterly Report SEC Filings 08/18/1998
JanOne Inc. (JAN) - SC 13G/A SEC Filings 06/09/1998
JanOne Inc. (JAN) - 10-Q - Quarterly Report SEC Filings 05/19/1998
JanOne Inc. (JAN) - 10-K405 - Current report SEC Filings 04/02/1998
JanOne Inc. (JAN) - DEF 14A SEC Filings 03/24/1998
JanOne Inc. (JAN) - PRE 14A SEC Filings 03/12/1998
JanOne Inc. (JAN) - SC 13G/A SEC Filings 02/13/1998
JanOne Inc. (JAN) - SC 13G/A SEC Filings 02/12/1998
JanOne Inc. (JAN) - SC 13G/A SEC Filings 02/11/1998
JanOne Inc. (JAN) - 10-Q - Quarterly Report SEC Filings 11/12/1997
JanOne Inc. (JAN) - 8-K - Current report SEC Filings 10/21/1997
JanOne Inc. (JAN) - 10-Q - Quarterly Report SEC Filings 08/12/1997
JanOne Inc. (JAN) - S-8 POS SEC Filings 06/05/1997
JanOne Inc. (JAN) - S-8 SEC Filings 06/05/1997
JanOne Inc. (JAN) - 10-K/A - Current report SEC Filings 06/05/1997
JanOne Inc. (JAN) - 10-Q - Quarterly Report SEC Filings 05/13/1997
JanOne Inc. (JAN) - 10-K/A - Current report SEC Filings 04/02/1997
JanOne Inc. (JAN) - 10-K405 - Current report SEC Filings 03/28/1997
JanOne Inc. (JAN) - DEF 14A SEC Filings 03/24/1997
JanOne Inc. (JAN) - PRE 14A SEC Filings 03/14/1997
JanOne Inc. (JAN) - SC 13G SEC Filings 02/14/1997
JanOne Inc. (JAN) - SC 13G/A SEC Filings 02/13/1997
JanOne Inc. (JAN) - SC 13G/A SEC Filings 02/10/1997
JanOne Inc. (JAN) - 424B1 SEC Filings 11/12/1996
JanOne Inc. (JAN) - 10-Q - Quarterly Report SEC Filings 11/12/1996
JanOne Inc. (JAN) - S-3 SEC Filings 11/04/1996
JanOne Inc. (JAN) - 10-Q - Quarterly Report SEC Filings 08/12/1996
JanOne Inc. (JAN) - SC 13G/A SEC Filings 07/10/1996
JanOne Inc. (JAN) - SC 13G SEC Filings 02/14/1996
JanOne Inc. (JAN) - SC 13G/A SEC Filings 02/14/1994

Press Releases

StockPrice Release
Janone confirms name change to alt5 sigma corporation and new ticker symbol to alts 07/12/2024
Janone announces plan to enhance stockholder value through strategic realignment 07/10/2024
Janone appoints vay tham as its chief revenue officer and president of its fintech subsidiary, alt5 sigma 06/26/2024
Alt5 sigma, a janone company, adds prepaid visa®️ card integration to alt5 settlement platform 06/25/2024
Janone's subsidiary, alt5, reports 91% year over year increase in transaction volume to us $289 million for april and may 2024 06/13/2024
Alt5 sigma, a wholly-owned subsidiary of janone, launches alt5 settlement platform aimed at the untapped $27.3 billion global digital content creation market 06/11/2024
Janone inc. added to the russell microcap® index 06/03/2024
Alt 5 sigma, a wholly-owned subsidiary of janone to present at the ifx expo, the world's largest online trading conference and tradeshow 05/28/2024
Janone closes acquisition of alt 5 sigma inc., a leading next generation blockchain fintech 05/16/2024
Janone regains compliance with nasdaq's listing requirements 03/15/2024
Janone to present at the dawson james 8th annual investment conference 09/21/2023
Janone to present in person and by video at h.c. wainwright's 25th annual global investment conference 08/31/2023
Janone earns us patent for the use of its novel formulation of low-dose naltrexone, jan123, to treat chronic pain 08/29/2023
Janone wins "best abstract" award at the ohio society of interventional pain physicians annual meeting 08/25/2023
Janone technologies announces closing of registered direct offering priced at-the-market under nasdaq rules 08/22/2023
Janone technologies announces registered direct offering priced at-the-market under nasdaq rules 08/18/2023
Janone to present prior phase ii data on diabetic neuropathy at the ohio society of interventional pain physicians annual meeting 08/18/2023
Janone files international patent application for methods of using low dose naltrexone to treat chronic pain 06/28/2023
Janone technologies announces closing of registered direct offering of common stock priced at-the-market 03/24/2023
Janone welcomes john bonfiglio -- veteran biotech executive, deal maker and strategist -- to top management team 03/23/2023
Janone technologies announces registered direct offering of common stock priced at-the-market 03/23/2023
Janone sells legacy business arca recycling to concentrate on growing biopharm businesses 03/22/2023
Janone charts ambitious strategic course for non-addictive pain management 01/26/2023
Janone inc. executes term sheet to acquire soin therapeutics llc 09/16/2022
Arca recycling, a subsidiary of janone inc., unveils new logo and website 07/05/2022
Janone inc. announces an improved formulation of jan101 06/28/2022
Janone inc. announces the issuance of u.s. patent covering a method of improving nerve function using jan101 06/07/2022
Janone sells geotraq to spyr technologies in a $13.5 million transaction 05/31/2022
Janone inc. acquires an option for the rights to a worldwide, exclusive license for a novel strategy for treating methamphetamine use disorder 12/07/2021
Arca recycling, a subsidiary of janone inc., launches two recycling programs in california in effort to reduce ghg emissions 10/27/2021
Arca recycling, a subsidiary of janone inc., sees major increase in appliance replacement contracts, estimated to push revenue of replacement programs to nearly $20 million, in addition to recycling business 10/19/2021
Arca recycling, a subsidiary of janone inc., awarded recycling contracts in pennsylvania with total estimated value of 20 million dollars for work in the state to continue through 2026 10/07/2021
Arca recycling, a subsidiary of janone inc., opens new pennsauken, nj, recycling center, launches new recycling programs 09/30/2021
Janone encouraged by recent fda communications regarding phase 2b clinical trial design of lead drug candidate jan101 09/28/2021
Janone selects cpc clinical research as trial manager for phase 2b study of jan101 for peripheral artery disease patients 07/22/2021
Janone readies clinical supply of lead product candidate jan101 for distribution to phase 2b trial sites 06/23/2021
Janone selects regulatory partner for phase 2b trial as investigational plan is prepared for fda filing 06/22/2021
Janone appoints internationally renowned expert on addiction nicholas goeders, ph.d. to scientific advisory board 06/15/2021
Janone engages dc consulting llc for government and private sector initiatives 06/10/2021
Janone advances toward initiation of phase 2b peripheral artery disease (pad) trial for lead product candidate jan101 06/08/2021
Janone announces closing of $6.0 million common stock offering 02/02/2021
Janone prices $6.0 million common stock offering 01/29/2021
Janone begins production of jan101 cgmp batch for phase 2b pad trial & potential covid-19 study 09/24/2020
Janone announces strategic plan to divest its legacy businesses 09/16/2020
Janone confirms stability data of jan101 development batch 09/03/2020
Janone selects partner for bottling and labeling of jan101 for potential clinical trials 08/28/2020
Janone advances its potential peripheral artery disease and covid-19 vascular inflammation treatment towards trial readiness 08/26/2020
Janone receives fda authorization for transfer of investigational new drug application for its sodium nitrite tablets 07/21/2020
The online shopping expert reveals exciting expansion plans 07/08/2020
Janone files non-timely 10-k with u.s. sec 03/30/2020
Janone inc. appoints tony giordano as chief scientific officer 12/02/2019
Janone acquires worldwide, exclusive license for promising treatment of peripheral arterial disease 11/25/2019
Janone inc. acquires worldwide, exclusive license for promising treatment of peripheral arterial disease (pad) 11/24/2019
Janone inc. reports earnings results for the third quarter ended september 28, 2019 11/18/2019
Janone files non-timely 10-q with sec 11/12/2019
Janone inc. announced delayed 10-q filing 11/11/2019
Janone inc. announces change in registered public accounting firm 10/17/2019
Janone inc., annual general meeting, nov 04, 2019 10/01/2019

More Headlines

News
JanOne Inc. added to the Russell Microcap® Index LAS VEGAS , June 3, 2024 /PRNewswire/ -- JanOne Inc. (Nasdaq: JAN), a multidisciplinary organization with a focus on healthcare and fintech, announced today that it has been added to the Russell Microcap® Index. The Russell Microcap® Index was launched on June 1, 2005 and measures the performance of the microcap segment of the US Equity market and consists of 1,000 securities, including Virgin Galactic HLDG, Skye Bioscience, Bitcoin Depot Inc., Core Scientific, Hut 8 Corp., and Sonder Holdings Inc., to name a few. 06/03/2024
ALT 5 Sigma, a wholly-owned subsidiary of JanOne to Present at the iFX Expo, the World's largest online trading conference and tradeshow LAS VEGAS, May 28, 2024 /PRNewswire/ -- JanOne Inc. (Nasdaq: JAN) a multidisciplinary organization with a focus on healthcare and fintech, announced today that its Fintech subsidiary, ALT 5 Sigma, will be presenting at the iFX Expo, the World's largest online trading conference and tradeshow held on June 18 until June 20 in Limassol, Cyprus. https://cyprus2024.ifxexpo.com/ The iFX Expo brings together thousands of C-Level Executives and Industry Peers from 120 countries. 05/28/2024
JanOne Closes Acquisition of ALT 5 Sigma Inc., a Leading Next Generation Blockchain Fintech LAS VEGAS , May 16, 2024 /PRNewswire/ -- JanOne Inc. (Nasdaq: JAN) announced today it has closed its previously announced acquisition of blockchain financial technology provider, ALT 5 Sigma Inc., and each of its wholly-owned subsidiaries. Launched in 2018, ALT 5 is a fintech that provides next generation blockchain-powered technologies to enable a migration to a new global financial paradigm. 05/16/2024
JanOne Regains Compliance with Nasdaq's Listing Requirements LAS VEGAS, March 15, 2024 /PRNewswire/ -- JanOne (Nasdaq: JAN), the biopharmaceutical company focused on developing non-addicting painkillers and novel treatments for the causes of pain, today announced that on March 13, 2024 it received a notification letter from the Listing Qualifications Staff of The Nasdaq Stock Market Inc. ("Nasdaq") indicating that the Company had regained compliance with the minimum bid price requirement set forth in Rule 5550(a)(2) of the Nasdaq Listing Rules (the "Minimum Bid Price Requirement"). As previously announced, the Company received a notification letter from Nasdaq on September 11, 2023, indicating that the closing bid price per share had been below $1.00 for a period of 30 consecutive business days and that the Company did not meet the Minimum Bid Price Requirement. 03/15/2024
Why Is JanOne (JAN) Stock Up 40% Today? JanOne (NASDAQ: JAN ) stock is on the rise Thursday despite a lack of news from the clinical-stage biopharmaceutical company. There haven't been any news press releases of filings with the Securities and Exchange Commission (SEC) from the company that would cause today's rally. 11/09/2023
JanOne to Present at the Dawson James 8th Annual Investment Conference Chief Medical Officer Dr. Amol Soin will explain innovative approaches to pain management and JanOne's development of non-addicting treatments for pain LAS VEGAS , Sept. 21, 2023 /PRNewswire/ -- JanOne (Nasdaq: JAN), the biopharmaceutical company focused on developing non-addicting painkillers and novel treatments for the causes of pain, will participate in investor sessions at the Dawson James Securities 8th Annual Investment Conference in Jupiter, Florida. 09/21/2023
JanOne to Present In Person and by Video at H.C. Wainwright's 25th Annual Global Investment Conference Chief Medical Officer Dr. Amol Soin will discuss innovative approaches to pain management and JanOne's development of non-addicting treatments for pain LAS VEGAS , Aug. 31, 2023 /PRNewswire/ -- JanOne (Nasdaq: JAN), the biopharmaceutical company focused on developing non-addicting painkillers and novel treatments for the causes of pain, will participate in investor sessions at the H.C. Wainwright 25 th Annual Global Investment Conference in New York City. 08/31/2023
JanOne Earns US Patent for the Use of its Novel Formulation of Low-Dose Naltrexone, Jan123, to Treat Chronic Pain The Broad Patent Coverage is a Major Milestone for the Commercial Success of Jan123 LAS VEGAS , Aug. 29, 2023 /PRNewswire/ -- JanOne (Nasdaq: JAN), the visionary biotech company dedicated to discovering non-addictive treatments for pain, as well as causes of pain, has earned a US patent for its innovative formulation of low-dose naltrexone, Jan123, for treating pain. The Broad Patent Coverage is a Major Milestone for the Commercial Success of Jan123 Jan123 is being developed to treat complex regional pain syndrome (CRPS), a rare and often life-altering condition characterized by severe pain and hypersensitivity to touch. 08/29/2023
JanOne Wins "Best Abstract" Award at the Ohio Society of Interventional Pain Physicians Annual Meeting Abstract explained Jan101's statistically significant reduction in pain and improvement in nerve conduction velocity in prior Phase II study. LAS VEGAS , Aug. 25, 2023 /PRNewswire/ -- JanOne (Nasdaq: JAN), the biopharmaceutical company focused on developing non-addicting painkillers and novel treatments for the causes of pain, has won a prestigious "Best Abstract" award for reporting that JanOne's treatment for diabetic neuropathy showed both effectiveness against pain and potential to improve nerve function. 08/25/2023
JanOne Technologies Announces Closing of Registered Direct Offering Priced At-The-Market under Nasdaq Rules LAS VEGAS, Aug. 22, 2023 /PRNewswire/ -- JanOne (Nasdaq: JAN) (the "Company"), a biopharmaceutical company specializing in developing non-addicting pain killers and treatments for underlying causes of pain, today announced that it has closed its previously announced registered direct offering for the purchase and sale of 899,348 shares of the Company's common stock (or prefunded warrants in lieu thereof) at a purchase price of $0.8811 per share of common stock (or prefunded warrant) in a registered direct offering priced at-the-market under Nasdaq rules. In addition, in a concurrent private placement, the Company issued unregistered warrants to purchase 899,348 shares of common stock at an exercise price of $0.7561 per share. 08/22/2023
JanOne Technologies Announces Registered Direct Offering Priced At-The-Market under Nasdaq Rules LAS VEGAS , Aug. 18, 2023 /PRNewswire/ -- JanOne (Nasdaq: JAN) (the "Company"), a biopharmaceutical company specializing in developing non-addicting pain killers and treatments for underlying causes of pain, today announced that it has entered into a definitive securities purchase agreement for the purchase and sale of 899,348 shares of the Company's common stock (or prefunded warrants in lieu thereof) at a purchase price of $0.8811 per share of common stock (or prefunded warrant) in a registered direct offering priced at-the-market under Nasdaq rules. In addition, in a concurrent private placement, the Company will issue unregistered warrants to purchase 899,348 shares of common stock at an exercise price of $0.7561 per share. 08/18/2023
JanOne to Present Prior Phase II Data on Diabetic Neuropathy at the Ohio Society of Interventional Pain Physicians Annual Meeting JAN101 Showed Statistically Significant Reduction in Pain and Improvement in Nerve Conduction Velocity in Prior Phase II study. LAS VEGAS , Aug. 18, 2023 /PRNewswire/ -- JanOne (Nasdaq: JAN), a biopharmaceutical company specializing in developing non-addicting pain killers and treatments for underlying causes of pain, will present prior data on Jan101's randomized double blind placebo-controlled trial in diabetic neuropathy patients. 08/18/2023
Penny Stocks To Watch: Why TOUR, JAN, ENDP, BRDS & WEJO Stock Are Moving Penny stocks to watch with news The post Penny Stocks To Watch: Why TOUR, JAN, ENDP, BRDS & WEJO Stock Are Moving appeared first on Penny Stocks to Buy, Picks, News and Information \| PennyStocks.com. 06/28/2022
Best Penny Stocks to Buy Now? 3 to Watch This Week Can these penny stocks make gains this month? The post Best Penny Stocks to Buy Now? 06/07/2022
Why JanOne Shares Are Skyrocketing Today JanOne Inc (NASDAQ: JAN) shares are trading higher by 42.40% at $3.56 after the company announced that a patent was issued that covers a method of improving nerve function using JAN101. JAN101 (formerly known as TV1001SR), is a potential treatment for peripheral artery disease (PAD), a. 06/07/2022
Why JanOne Shares Are Trading Higher Today JanOne Inc (NASDAQ: JAN) sold all of the assets, and none of the liabilities, of GeoTraq Inc., its wholly-owned subsidiary, to SPYR Inc (OTC: SPYR) for an aggregate of $13.5 million. The purchase price is payable in cash and shares of SPYR's common stock. 05/31/2022
JanOne Subsidiary Gets $1.6M Recycling Contract In Virginia, North Carolina JanOne Inc (NASDAQ: JAN) subsidiary ARCA Recycling, Inc. has received a contract to provide appliance recycling services to customers of a major electric utility in Virginia and North Carolina. The total value of the contract awarded is estimated to be ~$1.6 million. 12/16/2021
JanOne Enters Option Agreement For Rights To Novel Strategy To Reduce Methamphetamine Use JanOne Inc (NASDAQ: JAN) has acquired an option agreement for the rights to a novel strategy to reduce methamphetamine (meth) use by activating the Translocator Protein 18 kDa (TSPO). The agreement with LSU Health Shreveport and other intellectual property relating to TSPO's role in treating meth use disorder (MUD) provides JanOne with an opportunity to identify new drugs to enhance TSPO activity. 12/07/2021
ARCA Recycling, a Subsidiary of JanOne Inc., Sees Major Increase in Appliance Replacement Contracts, Estimated to Push Revenue of Replacement Programs to Nearly $20 Million, in Addition to Recycling Business MINNEAPOLIS, Oct. 19, 2021 /PRNewswire/ -- ARCA Recycling, Inc., a wholly owned subsidiary of JanOne Inc. (NASDAQ: JAN), has seen major growth in its appliance replacement programs throughout the past 12 months, with the addition of new contracts signed this year that total more than $3 million. It is estimated that these new contracts could increase ARCA's revenue from the replacement programs to approximately $20 million in 2021. 10/19/2021
ARCA Recycling, a Subsidiary of JanOne Inc., Opens New Pennsauken, NJ, Recycling Center, Launches New Recycling Programs MINNEAPOLIS, Sept. 30, 2021 /PRNewswire/ -- ARCA Recycling, Inc., a wholly owned subsidiary of JanOne Inc. (NASDAQ: JAN), opened a new appliance recycling center last month in Pennsauken, New Jersey. 09/30/2021
JanOne Encouraged By Recent FDA Communications Regarding Phase 2B Clinical Trial Design of Lead Drug Candidate JAN101 LAS VEGAS, Sept. 28, 2021 /PRNewswire/ -- JanOne Inc. (Nasdaq: JAN), a company that focuses on the development of treatments for conditions that cause severe pain – in conjunction with its continuing focus on the development of drugs with non-addictive, pain-relieving properties – today announced that it is revising its development strategy based on recent communications with the U.S. Food and Drug administration (FDA) for its upcoming clinical trial of lead drug candidate JAN101 as a treatment for Peripheral Artery Disease (PAD). 09/28/2021
JanOne Selects CPC Clinical Research as Trial Manager for Phase 2b Study of JAN101 for Peripheral Artery Disease Patients LAS VEGAS, July 22, 2021 /PRNewswire/ -- JanOne Inc. (Nasdaq: JAN), a company focused on developing treatments for conditions that cause severe pain and drugs with non-addictive, pain-relieving properties, today announced that it has selected CPC Clinical Research (CPC), a full-service academic research organization (ARO), as manager for its upcoming Phase 2b clinical trial of lead product candidate JAN101 for treating Peripheral Artery Disease (PAD). CPC will be responsible for the planning, organization, day-to-day execution, and management of the Company's study, and will collaborate with JanOne's appointed regulatory partner Avania, announced last month. 07/22/2021
JanOne Readies Clinical Supply of Lead Product Candidate JAN101 for Distribution to Phase 2b Trial Sites LAS VEGAS, June 23, 2021 /PRNewswire/ -- JanOne Inc. (Nasdaq: JAN), a company focused on developing treatments for conditions that cause severe pain and drugs with non-addictive, pain-relieving properties, today announced that its clinical packaging partner Xerimis has received the bottled clinical batch of JAN101 for the upcoming Phase 2b trial for treating Peripheral Artery Disease (PAD) and is readying the supply for labeling and distribution to clinical sites throughout the U.S. "We are pleased to report that our clinical supply of JAN101 is now ready for near-term release to our expected clinical trial sites in the upcoming Phase 2 clinical trial," said Tony Isaac, President and Chief Executive Officer of JanOne. "We are fully prepared and look forward to FDA approval of our new protocol. 06/23/2021
JanOne Appoints Internationally Renowned Expert on Addiction Nicholas Goeders, Ph.D. to Scientific Advisory Board LAS VEGAS, June 15, 2021 /PRNewswire/ -- JanOne Inc. (Nasdaq: JAN), a company focused on developing treatments for conditions that cause severe pain and drugs with non-addictive, pain-relieving properties, today announced the appointment of Nicholas E. Goeders, Ph.D. 06/15/2021
JanOne Engages DC Consulting LLC for Government and Private Sector Initiatives LAS VEGAS, June 10, 2021 /PRNewswire/ -- JanOne Inc. (Nasdaq: JAN), a company focused on developing treatments for conditions that cause severe pain and drugs with non-addictive, pain-relieving properties, today announced that it has engaged the services of DC Consulting LLC, a strategy and management consulting firm specializing in government affairs, regulatory guidance, marketing strategy, and public relations services relating to healthcare, pharmaceuticals, drug policy and prevention, law enforcement, and building healthy communities. DC Consulting was founded by former public officials James W. 06/10/2021
JanOne Announces Closing of $6.0 Million Common Stock Offering LAS VEGAS, Feb. 2, 2021 /PRNewswire/ -- JanOne Inc. (Nasdaq: JAN), a company focused on developing treatments for conditions that cause severe pain and drugs with non-addictive, pain-relieving properties, today announced the closing of previously announced its securities offering with... 02/02/2021
JanOne Prices $6.0 Million Common Stock Offering LAS VEGAS, Jan. 29, 2021 /PRNewswire/ -- JanOne Inc. (NASDAQ: JAN), a company focused on developing treatments for conditions that cause severe pain and drugs with non-addictive, pain-relieving properties, today announced it has entered into a securities purchase agreement with... 01/29/2021
JAN Stock: JanOne Shares Skyrocket as Part of Reddit Run-Up Fever JanOne (JAN) stock is soaring higher Thursday morning as it joins other stocks being boosted by Reddit and other social media users. The post JAN Stock: JanOne Shares Skyrocket as Part of Reddit Run-Up Fever appeared first on InvestorPlace. 01/28/2021
JAN Stock Price Increases Over 198% Pre-Market: Why It Happened The stock price of Janone Inc (NASDAQ: JAN) has increased over 190% pre-market today. This is why it happened. 01/28/2021
JanOne Inc. (JAN) CEO Tony Isaac on Drug Candidate JAN101 - Telebriefing and Corporate Update Call Transcript JanOne Inc. (NASDAQ:JAN) Telebriefing and Corporate Update Call August 25, 2020 16:15 ET Corporate Participants Tony Isaac - Chief Executive Officer Tony Giordano - Chief Scientific Officer Amol Soin - Chief Medical Officer Conference Call Participants Jeremy Roe - Integra Robert Carlson - Janney Montgomery Scott Presentation Operator Good afternoon everyone and thank you for joining us for the JanOne Telebriefing and Corporate Update Call. 08/25/2020
JanOne to Present at The LD 500 Virtual Conference JanOne Inc. (Nasdaq: JAN), a company focused on developing treatments to market for conditions that cause severe pain and drugs with non-addictive, pain-relieving properties, today announced that it will be presenting at the 12th Annual LD 500 Conference on Thursday, September 3, 2020 at 3:00 PM ET. Tony Giordano, PhD, Chief Scientific Officer of JanOne, will present virtually to an online audience. 08/19/2020
/C O R R E C T I O N -- JanOne/ JanOne Inc. (Nasdaq: JAN), a company focused on bringing treatments to market for conditions that cause severe pain and drugs with non-addictive, pain-relieving properties, together with its manufacturing partner, has successfully completed the formulation of JAN101, its potential treatment for Peripheral Artery Disease (PAD) expected to soon be in Phase 2b trials. In addition, JAN101 is planned for use to treat COVID-19 vascular complications pending approval of the IND submission, expected to be completed in late August 2020. 08/11/2020
JanOne Engages CATO SMS, a World-Leading CRO, to Assist in the Development of JAN101 to Treat COVID-19 Vascular Complications JanOne Inc. (Nasdaq: JAN), a company focused on bringing treatments to market for conditions that cause severe pain and drugs with non-addictive, pain-relieving properties, has entered into an agreement with CATO SMS, a world-leading, international regulatory and clinical contract research organization (CRO). CATO SMS will assist JanOne in expanding its current FDA authorized Investigational New Drug (IND) for JAN101, an oral, sustained release formulation of sodium nitrite, to treat vascular complications to potentially restore endothelial cell function in COVID-19 patients. In addition, JAN101 is expected to enter Phase 2b trials in early 2021 to treat Peripheral Artery Disease (PAD). 08/06/2020
JanOne Changes Internal Drug Candidate Name from TV1001SR to JAN101 JanOne Inc. (Nasdaq: JAN), a company focused on bringing treatments to market for conditions that cause severe pain and drugs with non-addictive, pain-relieving properties, announces a internal name change for its current drug candidate from TV1001SR to JAN101, soon to enter Phase 2b clinical trials as a potential treatment Peripheral Artery Disease (PAD). The name change will be effective immediately and will be used in all its current and future clinical trials, Indications for a New Drug, clinical and research studies planned to be conducted in the future. 08/04/2020
JanOne bolsters its scientific advisory board with two leaders in the medical field for vascular regeneration and interventional pain JanOne Inc. (NASDAQ:JAN), a company focused on finding treatments for conditions that cause severe pain and bringing to market drugs and therapies with non-addictive pain-relieving properties has added two members to its impressive scientific advisory board. John Cooke, MD, PhD will contribute his esteemed depth of vascular expertise to help guide the success of our clinical therapeutic for the treatment of PAD. Alan Kaye, MD, PhD, is an internationally renowned anesthesiologist and pharmacologist whose pain management research and clinical formulation expertise will play a critical role in advancing our efforts to bring non-addictive pain solutions to market. 07/30/2020
3 ETFs For This Week's Earnings Parade Second-quarter earnings season continues in force this week — and it hasn't been to bad so far on a statistical basis. To date, 26% of the companies in the... 07/27/2020
JanOne Receives FDA Authorization for Transfer of Investigational New Drug (IND) Application for its Sodium Nitrite Tablets JanOne Inc. (NASDAQ: JAN), a company focused on bringing treatments to market for conditions that cause severe pain and drugs with non-addictive pain-relieving properties, has received confirmation from the Federal Food and Drug Administration (FDA) for the investigational new drug (IND) sponsorship transfer covering its sodium nitrite tablets previously held by Soin Neuroscience. The sodium nitrite sustained release tablet is the clinical candidate TV1001SR, formulated to treat PAD and other vascular conditions. Manufacturing of TV1001SR is underway and phase 2b trials for PAD are expected to begin later this year. There is no current treatment for PAD and over 8.5 million Americans suffer from the disease. 07/21/2020
The perils of waiting 10 days or more to get a coronavirus test result: ‘It’s only marginally better than not doing the testing’ When people first started showing signs of coronavirus in the U.S. in March they were told they needed special permission to get tested. If they didn’t fit... 07/17/2020
Dr. Rakesh Patel, internationally recognized scientist in nitric oxide and redox biology, and Dr. Timothy Ness, a pain mechanisms and medication expert, join JanOne's Scientific Advisory Board JanOne Inc. (NASDAQ:JAN), a company focused on finding treatments for conditions that cause severe pain and bringing to market drugs and therapies with non-addictive pain-relieving properties, continues to broaden the medical and clinical competency of its scientific advisory board. We are proud to announce the addition of two renowned researchers from the University of Alabama at Birmingham, Rakesh Patel, PhD, and Timothy Ness, MD, PhD. Dr. Patel lends significant scientific knowledge in molecular and cellular pathology and Dr. Ness brings an extensive pain research portfolio with focus on mechanisms of pain for various indications. 07/08/2020
The Online Shopping Expert Reveals Exciting Expansion Plans Already recognised as one of the UK’s leading platforms for savvy online shoppers, the company will now amplify its discount codes categories. 07/08/2020
One of the nation's most renowned pain experts, Dr. Edgar Ross, joins JanOne's Scientific Advisory Board JanOne Inc. (NASDAQ:JAN), a company focused on finding treatments for conditions that cause severe pain and bringing to market drugs and therapies with non-addictive pain-relieving properties announced today that Edgar Ross, MD will join the company's scientific advisory board. Dr. Ross is the current Director of the Pain Management Center at Brigham and Women's Hospital and associate professor of anesthesia at Harvard Medical School. He brings over 40 years of experience in the medical field and is a highly regarded pain specialist. Among his many accomplishments, Dr. Ross has published over 100 manuscripts on pain management, participated in numerous pain-related clinical trials for some of the world's top pharmaceutical companies, and served as Chairman of Pfizer's medical and academic partnership on pain. 06/30/2020
These 5 giant stocks are driving the U.S. market now, but bigger is not always better Powerful stock-market leaders ultimately take a fall, writes Mark Hulbert. 06/26/2020
JanOne taps distinguished chemist Dr. Doug Flanagan as chief formulation advisor JanOne Inc. (NASDAQ: JAN), a company focused on bringing treatments to market for conditions that cause severe pain and drugs with non-addictive pain relieving properties, continues to build a world-class team of biopharma experts with the addition of Douglas Flanagan, PhD as the company's chief formulation advisor. Dr. Flanagan will work directly with CoreRX, JanOne's manufacturing partner to ensure the integrity of TV1001SR, the company's clinical candidate for treating Peripheral Artery Disease (PAD) expected soon to enter phase 2 trials. He will also play an integral role for the potential identification and advancement of other clinical candidates to treat pain as the company hopes to broaden its pipeline in the near future. 06/25/2020
JanOne Launches Strategic Alternatives Process for Legacy Businesses JanOne Inc. (Nasdaq:JAN), a company focused on bringing treatments to market for conditions that cause severe pain and drugs with non-addictive pain relieving properties, today announced the commencement of a strategic alternative process for its legacy businesses in an effort to enhance shareholder value. This review process will be conducted with the assistance of the company's financial and legal advisors and will consider the full range of potential strategic alternatives with respect to its legacy businesses. This will include but is not limited to, acquisitions, business combinations, joint ventures, spinoffs, public and private capital raises, recapitalization, and sale transaction options. 06/18/2020
Entry Points Count Intraday volatility for stocks, whether $10 numbers or growthies selling in three digits does range between 5% and 10%. You see such action in U.S. Steel, Alcoa, Energy Transfer, General Electric and Ford Motor – all under $10 paper, but with few friends. 06/18/2020
Future of `Tejas’ with Indigenous Kaveri Engine: A long way to go “Kaveri is a low bypass twin-spool turbofan jet engine which was slated to provide an 80 KN power pack and adequate ‘thrust to weight’ ratio required by a modern fighter jet configuration,” explained an aeronautical engineer. 06/14/2020
Here are the biggest stock-market bets among institutional and retail investors, ranked What it all means is a little harder to figure out... 06/09/2020
What a great time to start a new business Downturns and bear markets present a great opportunity for entrepreneurs to start a new business. 05/28/2020
Dow futures fall as Wall Street weighs states’ reopenings, China-U.S. tensions U.S. stock-index futures fall sharply in thin trading Sunday evening as investors contend with state reopenings amid signs of brewing conflict between China... 05/04/2020
Beaten-up value stocks are offering opportunities of a generation, fund manager says One fund manager is convinced value stocks will come back. Here’s where he is invested. 04/29/2020
GE And Ford: 2 Of The Weakest Charts In April GE and Ford have experienced rotten March-April trends in trading action. Despite a major bounce higher in the U.S. stock market, the two blue-chips remain unde 04/29/2020
ACB, MYGN among premarket losers Salarius Pharmaceuticals (NASDAQ:SLRX) -53% after pricing equity offering.Resonant (NASDAQ:RESN) -31% after pricing equity offering.Myriad Genetics (NASDAQ:MYGN) -30% on Q2 earnings.Zogenix (NASDAQ:ZG 02/07/2020
100 Biggest Movers From Yesterday Gainers Schrodinger, Inc. (NASDAQ: SDGR) shares jumped 68.5% to close at $28.64 on Thursday after the company priced its IPO at $17 per share. Yield10 Bioscience, Inc. (NASDAQ:... 02/07/2020
Mid-Morning Market Update: Markets Open Higher; Twitter Beats Revenue Estimates Following the market opening Thursday, the Dow traded up 0.14% to 29332.00 while the NASDAQ rose 0.39% to 9,545.86. The S&P also rose, gaining 0.27% to 3,343.84. Leading and... 02/06/2020
JanOne strikes agreement with CoreRx, a leading cGMP contract manufacturer, for Phase 2b clinical formulation and development JanOne Inc. (NASDAQ: JAN), a company focused on bringing treatments to market for conditions that cause severe pain and drugs with non-addictive pain relieving properties, has executed a manufacturing agreement for the formulation and manufacturing of TV1001SR, a treatment for Peripheral Artery Disease (PAD). PAD affects over 8.5 million people in the United States and there are currently no direct treatments for PAD on the market today. Research Market Future (MRFR) values the PAD market at $3.47 billion in the United States by 2023.1" 02/06/2020
Amol Soin, MD, One Of The Nation's Leading Pain Experts, Named As JanOne's Chief Medical Officer JanOne Inc. (NASDAQ:JAN), a company focused on finding treatments for conditions that cause severe pain and bringing to market drugs and therapies with nonaddictive pain-relieving properties, announced the addition of Amol Soin, MD as the company's chief medical officer. Dr. Soin has been recognized multiple times as one of America's Top Doctors and is the recipient of the Patient's Choice Award, an honor given only to the top 1% of physicians in the country. 01/28/2020
JanOne Scientific Advisory Board Chair and Leading Pain Expert Featured on ABC-7 WJLA America This Week JanOne Inc. (NASDAQ:JAN) Scientific Advisory Board Chair, Dr. Christopher Kevil sat down with Eric Bolling, JanOne's President and Chairman and host of America This Week, to discuss the effects of the company's lead drug candidate, TV1001SR, for the treatment of peripheral artery disease (PAD) and associated pain. Dr. Kevil was joined by renowned pain expert, Dr. Amol Soin, and both provided their insights and perspective for an approach that treats the mechanisms of a disease process, such as in PAD, and concurrently can have significant pain relieving qualities. Of particular interest was how in prior studies TV1001SR was able to treat both the underlying condition and the associated pain with no addictive repercussions. The company believes that this could mitigate the need for prescription opioids that often come with a risk for addiction, when patients are suffering from severe pain. 01/23/2020
Leading Cardiovascular Researcher And PAD Treatment Pioneer, Dr. Christopher Kevil, To Chair JanOne Scientific Advisory Board JanOne Inc. (NASDAQ:JAN) appoints Christopher Kevil, Ph.D., a pioneer in nitrite based PAD treatment, to lead its scientific advisory board. In this role, Dr. Kevil will chair the Company's scientific advisory board to advise on drug development and technology strategy, assist with clinical research, and help to advance its lead candidate TV1001SR, for the treatment of PAD. Dr. Kevil is considered a foremost expert in the development and analysis of various small molecules, biologics, disease indications, pharmaceutical, medical device, and drug delivery systems. 01/16/2020
History will repeat itself when it comes to stocks in 2020, Goldman Sachs says The signing of a “phase one” trade deal between the U.S. and China after months of negotiations and tensions looks set to boost stocks further. 01/14/2020
The big booths of CES 2020 From spectacular bending screens to Spider-Man, from giant slides to somewhere quiet to sit, here are the most extravagant booths from this year's tech shindig in Las Vegas. 01/08/2020
Why buying and selling a house could soon be as simple as trading stocks Artificial intelligence in housing won’t just eliminate Realtors. It could completely change the way we buy, sell and live. 12/29/2019
JanOne Names Tony Giordano, Ph.D., as Chief Scientific Officer JanOne Inc. (NASDAQ:JAN) a company focused on reducing opioid addiction by finding treatments for conditions accompanied by pain and bringing to market drugs and therapies with nonaddictive pain-relieving properties, announced the hiring of Tony Giordano, Ph.D. to serve as its Chief Scientific Officer. 12/03/2019
JanOne Acquires Worldwide, Exclusive License for Promising Treatment of Peripheral Arterial Disease (PAD) JanOne Inc. (NASDAQ: JAN), a company focused on reducing opioid addiction by finding treatments for conditions accompanied by pain and bringing to market drugs and therapies with nonaddictive pain-relieving properties, today announced a licensing agreement for TV1001SR, a treatment for Peripheral Artery Disease, commonly called PAD. The agreement with LSU Health Shreveport, UAB Research Foundation, and TheraVasc, Inc., gives JanOne a worldwide, exclusive license for TV1001SR along with a portfolio of 30 patents and other intellectual property relating to the sustained release of sodium nitrite. 11/25/2019
JanOne Names America This Week Host And Financial Commentator Eric Bolling As President And Chairman LAS VEGAS, Sept. 12, 2019 /PRNewswire/ -- JanOne, Inc. (NASDAQ: JAN), a newly launched initiative with the focused intent of offering innovative, actionable solutions to end the opioid crisis, is proud to name host of America This Week and financial commentator Eric Bolling as its President and Chairman. As one personally affected by the opioid scourge, Bolling has dedicated himself to fighting the opioid epidemic by executing the mission of JanOne: To help to end the opioid crisis by, among other things, developing revolutionary pain medications to replace today's highly addictive and often fatal opioids. "I am elated to become part of JanOne and to help fulfill the mission of developing alternative, non-opioid pain drugs," Bolling said. 09/12/2019
ARCA Now Doing Business as JanOne, Trades Under New Nasdaq Ticker Symbol JAN LAS VEGAS, Sept. 11, 2019 /PRNewswire/ -- Appliance Recycling Centers of America, Inc. (NASDAQ: JAN) today announced that, on September 10, 2019, the company has been renamed JanOne Inc. and, effective this morning, now trades under the ticker symbol JAN, with a new CUSIP number (47089W 104). The company's new name, JanOne, expresses the start of a new day in the fight against the opioid epidemic. January One is the first day of a New Year – a day of optimism, resolution, and hope. JanOne affirms the company's strategic commitment to fresh thinking and innovative means to assist in ending the worst drug crisis in our nation's history. 09/11/2019
Appliance Recycling Centers of America (a) ARCA Inc (ARCI) hits 52-week high \| AlphaStreet Shares of Appliance Recycling Centers of America (NASDAQ: ARCI) opened up about 80% at $8.50 today reaching a new 52-week high as its subsidiary GeoTraq announced the transition from GSM to LTE-M/NB-IoT connectivity, creating a new class of Mobile IoT modules. ARCI stock had more than doubled (up 111%) since the beginning of 2019 and had gained 21% in the past 12 months. 04/25/2019
Half of investment-grade bonds are only one step away from junk status Companies binged on cheap credit, and they’re about to pay the price. 01/08/2019
You and I Are Not Doomed: Market Recon But we are going to have to work harder from now on. 01/18/2018
What Is the New York Stock Exchange? \| The Motley Fool The New York Stock Exchange is the largest and oldest stock exchange in the United States. 08/11/2016

Unlock

JAN Ratings Summary

JAN Quant Ranking